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In eutherian mammals, dosage compensation between XX females and XY males 
occurs in part through X chromosome inactivation (XCI) of one X homolog per cell in 
females. XCI was previously assumed to be complete across the X-specific regions of X 
chromosomes, but recently genes outside the pseudoautosomal regions (PARs) have been 
observed to exhibit low but significant expression from the inactive X in several species. 
These genes are termed XCI “escapers”. XCI escape introduces gene expression variation 
between females and males and inflates variation among females. However, it remains 
unclear whether XCI escape is generally a “bug” in the XCI system – that is, merely a 
consequence of inefficient XCI – or a “feature” required for normal biological function. 
By comparing XCI profiles across mammals, we can gain insight into the 
evolutionary history of XCI and XCI escape, with the hope that this will improve our 
understanding of their mechanisms and functions. Here, I describe three analyses motivated 
by these goals. First, we expanded upon earlier findings to show that human XCI escapers 
exhibit a greater degree of strong purifying selection, as well as higher and broader gene 
expression than inactivated genes in both sexes. These results suggest a role for gene 
expression patterns in determining XCI status after divergence from the Y chromosome. 
 Next, we generated a novel XCI profile for the domestic dog from single cell RNA-
seq from two female F1 crossbreed dogs. Cell-level gene expression data was used to classify 
 X genes as showing either monoallelic or bialleleic expression in multiple cells. Using this 
method, we identified 45 putative XCI escapers and 98 putative X-inactivated genes. 
 Lastly, we performed a comparative analysis of XCI profiles across human, mouse, 
dog, and opossum 1:1 X orthologs. This analysis revealed that XCI escape is highly lineage-
specific. Despite this, XCI escapers in these species overlap highly in their Gene Ontology 
biological process annotations. XCI escapers also appear to be under greater evolutionary 
constraint than inactivated genes within most species, though the magnitude varies. 
 Overall, our findings suggest that the forces driving XCI escape evolution vary 
extensively across genes within and between species. 
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 1 
INTRODUCTION  
AND LITERATURE REVIEW 
 
X chromosome inactivation and escape 
In species with chromosomal sex determination, one or more sex chromosomes may 
encode genes that are essential in both sexes. This introduces the problem that females and males 
may have intrinsically different stoichiometry between sex chromosome and autosomal gene 
products, potentially causing deleterious effects. Susumu Ohno and others hypothesized that sex 
chromosome dosage compensation processes function at the transcription level to equalize gene 
expression between males and females, and between the sex chromosomes and the ancestral 
autosomes from which they evolved (Ohno 1967). 
A wide variety of species have evolved some form of sex chromosome dosage 
compensation. In eutherian mammals, dosage compensation between XX females and XY males 
is achieved through a process known as X chromosome inactivation (XCI), or lyonization (Lyon 
1961, 1962). During XCI, one of the two X chromosomes in each female somatic cell is 
epigenetically silenced early in embryonic development. This process involves extensive 
chromatin remodeling facilitated by the recruitment of polycomb repressor complexes to the 
inactivated X (Xi) (de Napoles et al. 2004), which ultimately produces a condensed 
heterochromatic structure known as the Barr body (Barr and Bertram 1949). As embryonic 
development proceeds, the epigenetic state of the Xi is transmitted down each cell’s lineage, 
producing a mosaic pattern of X allele expression in the fully developed organism.  
XCI was previously assumed to be complete across the X-specific regions of X 
chromosomes, i.e. the regions that no longer recombine with the Y chromosome. However, 
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genes outside the pseudoautosomal regions (PARs) have more recently been observed to exhibit 
unique epigenetic profiles (Miller and Willard 1998), and later, low but significant expression in 
several therian and eutherian species (Carrel and Willard 2005; Wang et al. 2012; Wang et al. 
2014; Berletch et al. 2015). These genes, referred to as XCI “escapers”, include the long non-
coding RNA XIST, which is solely transcribed from Xi and facilitates the recruitment of XCI 
machinery to the rest of the chromosome during lyonization (Brown et al. 1991). XCI escape at 
another non-PAR human gene was later reported (Carrel and Willard 1999), and the same group 
went on to identify many more non-PAR human X genes that escaped XCI to some degree 
(Carrel and Willard 2005). 
In this first major study of XCI escape, Carrel and Willard performed semi-quantitative 
RT-PCR assays on nine human-murine hybrid fibroblast cell lines (Carrel et al. 1999) to assess 
the degree of expression from the Xi allele relative to the active X (Xa) allele in each line. 
Because this method was only semi-quantitative, they used an Xi to Xa expression ratio of greater 
than or equal to 10% as the lower limit at which biallelic expression was considered to be 
significant. Using this method, they tested over 600 of the approximately 1,100 human X genes 
annotated at that time and found that over 200 of them show some degree of significant biallelic 
expression. They further broke down XCI escapers by the proportion of human-murine hybrid 
cell lines in which they escaped, calling genes escaping in three to six of the nine cell lines 
“heterogeneous” escapers, and those escaping in seven or more of the nine cell lines “consistent” 
escapers. Genes escaping in one or two of the nine cell lines were considered to be X inactivated. 
Using these definitions, they reported 94 consistent XCI escapers, 62 heterogeneous escapers, 
and 458 X-inactivated genes. This study also confirmed and refined an earlier observation that 
human XCI escapers are not randomly distributed across the X chromosome (Miller and Willard 
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1998): most are clustered together in the distal part of the p arm of the chromosome, which 
diverged from the Y chromosome more recently than the rest of the chromosome (Ross et al. 
2005).  
 
Extension of the human XCI profile 
The expression level-based definition of XCI escape introduced by Carrel and Willard 
(2005) has been widely used in other studies of XCI profiles – i.e. which genes escape or are 
subject to X inactivation in a given species. However, more recent studies have expanded the 
catalog of human XCI escapers by using a different, but strongly correlated biological feature: 
DNA methylation. Cotton et al (2015) showed that methylation levels at CpG islands in a gene’s 
transcription start site (TSS) were strongly predictive of its XCI status in the Carrel and Willard 
2005 study, with strongly female-biased TSS methylation levels correlating with X-inactivation 
and lower female bias correlating with XCI escape. Additionally, Schultz et al. (2015) 
demonstrated that gene body non-CpG methylation (mCH) levels showed the opposite pattern, 
with escapers showing a higher female bias in mCH levels than X-inactivated genes. Using 
methylation data to identify escapers allowed these two groups to assay many weakly-expressed 
genes that could not be tested using allele-specific expression. 
Both of these studies also made the innovation of assaying XCI profiles in multiple 
tissues and cell lines and found that a gene’s XCI status can vary across tissues within the same 
individual. Furthermore, many of the tissues used in the Cotton et al. study included multiple – 
sometimes hundreds – of individuals. With this data, they were able to show that heterogeneous, 
or in their terms, “variable” XCI escapers are common, but that most are either primarily X-
inactivated or primarily escape across all individuals. Additionally, they found few genes that 
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showed extremely tissue-specific escape. These findings demonstrated that XCI escape is an 
under-investigated source of gene expression variation across females, as well as between 
females and males.  
 
Importance to the field 
The primary motivation for studying XCI and XCI escape is to gain new insights into the 
evolution of sex chromosome dosage compensation, which is a quintessential example of large-
scale epigenetic regulation, and an essential biological process in many species. Misregulation of 
sex chromosome dosage compensation can have widespread deleterious effects. For instance, 
failure to achieve upregulation of the single male X in Drosophila results in male lethality 
(Belote and Lucchesi 1980 a, b), and failure to inactivate an additional maternal X causes 
embryonic lethality in mouse (Goto and Takagi 1998, 2000). In certain human autoimmune 
diseases and cancers, reactivation of the Xi can produce global transcriptional effects that are 
believed to contribute to the disease phenotype (Agrelo and Wutz 2010 a, b). 
Despite the high conservation of some form of sex chromosome dosage compensation 
across a wide range of species, there is extensive variation in the mechanisms by which it is 
achieved. In C. elegans, dosage compensation between XX hermaphrodites and XO males 
occurs by halving expression from both hermaphrodite X chromosomes (Hsu and Meyer 1994). 
In Drosophila, transcription from the single X in XY males is doubled to be equivalent to XX 
females (Mukherjee and Beermann 1965). In avians, down regulation of transcription from the Z 
chromosome in ZZ males appears to occur on a gene-by-gene basis rather than on the 
chromosome level (Itoh et al. 2007; Mank and Ellegren 2009). In contrast to the random XCI 
observed in eutherian mammals, marsupials display paternal XCI, meaning that only the paternal 
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X chromosome is silenced in XX females (Wang et al. 2014). The vastly different nature of these 
schemes indicates that they have evolved independently across different animal phyla, but it is 
unclear to what extent they are homologous or convergent within phyla. In eutherian mammals, 
this question is particularly interesting given the wide variety in the degree of X and Y 
chromosome divergence and PAR size across species (Raudsepp and Chowdhury 2015), which 
may result in dosage compensation of different X genes across species. 
Another motivation to study XCI and XCI escape is to understand what roles each of 
these processes play in human health and disease. An excess of Mendelian disorders have been 
mapped to the X chromosome compared to the rest of the human genome (Hamosh et al. 2005), 
and it is expected that the X chromosome also plays unique roles in complex genetic diseases. 
This is supported by the fact that many complex diseases show a pronounced sex bias in 
incidence, prevalence, etiology, or symptoms (Patsopoulos et al. 2007; Ober et al. 2008), and the 
possibility that X is enriched for sexually antagonistic alleles (Morrow and Connallon 2013). As 
mentioned above, XCI escape may contribute to phenotypic differences between the sexes. This 
idea has driven a great deal of interest in XCI escape among human geneticists, and there is some 
evidence to support it for at least a few genes. For example, one recent study found that a subset 
of human XCI escapers show a significant male-specific enrichment for somatic loss-of-function 
mutations across a variety of cancers (Dunford et al. 2017). The authors suggested that these 
genes might have roles as tumor suppressors, and that their biallelic expression in females 
confers a protective effect in the event that one allele acquires a loss-of-function mutation. 
XCI and XCI escape may also contribute to phenotypic differences among females. Due 
to the stochastic nature of random X inactivation in early development, XX individuals have 
different X allelic expression ratios at the tissue level based on the degree of Xi mosaicism 
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within that tissue. This “XCI skewing” can be extreme, with some individuals showing 
effectively monoallelic expression within a given tissue (Busque et al. 1996). Variable XCI 
escape also introduces the potential for allelic expression ratio variation among females based on 
whether or not a given gene escapes XCI in each individual (Peeters et al. 2014).  
 
Research questions 
While research over the past fifty years has illuminated many aspects of XCI and XCI 
escape, several aspects of both phenomena remain poorly understood. First among these are the 
details of the physical mechanisms of XCI and XCI escape. Despite the many technological 
advances that have occurred since their discovery, both XCI and XCI escape are still difficult to 
observe experimentally because they occur early in development and with extensive intrinsic 
variation. This is especially true for human studies, which have much more limited access to 
embryos and a greater extent of atypical epigenetic states in cell lines (Shen et al. 2008; Fan and 
Tran 2011) than model organisms. The functional significance and consequences of XCI escape 
also remain uncertain. As mentioned above, it has been suggested that XCI escape could be 
essential to normal female development. However, it has also been argued that XCI escape is 
simply the result of inefficient XCI, with no little or functional impact (Migeon 2014). As with 
the physical mechanisms of XCI and XCI escape, these two models are difficult to evaluate 
experimentally.  
Understanding the evolutionary history of XCI escape might help elucidate its 
mechanisms as well as its functional significance. The widely accepted model for XCI and XCI 
escape evolution is that XCI evolved gradually in response to loss of Y chromosome gene 
content (Ohno 1967; Charlesworth 1991; Skaletsky et al. 2003), and that XCI escape is an 
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intermediate state in this process (Jegalian and Page 1998). At a glance, the relationship between 
Y gametolog functionality and X gametolog inactivation seems straightforward: XCI rarely 
occurs in the PARs (Berletch et al. 2011), which contain most of the remaining functional Y 
genes, and recent lineage-specific Y gametolog loss within the eutherian clade correlates with 
XCI of the corresponding X gametolog (Jegalian and Page 1998). However, there are many 
human X genes that do not neatly fit this pattern, such as X-inactivated genes that have retained 
functional Y gametologs, and XCI escapers located in old evolutionary strata that lost their Y 
gametologs many millions of years ago (Pandey, Wilson-Sayres, and Azad 2013; Wilson-Sayres 
and Makova 2013). These apparent discrepancies motivate the central goal of this dissertation: to 
gain insight into whether XCI escape is simply a “bug” in the XCI system, or if it can also be a 
functional “feature” maintained by direct or indirect natural selection. 
If XCI escape is solely a neutral consequence of inefficient XCI, we would expect that a 
gene’s XCI status would be determined primarily by its evolutionary relationship to the Y 
chromosome. Mammalian X and Y chromosome divergence is believed to have occurred in a 
stepwise manner as a consequence of large-scale structural rearrangements on the Y 
chromosome inhibiting X-Y recombination (Ross et al. 2005). Therefore, if the assumptions of 
the “bug” model of XCI escape hold for all genes, we would expect that X genes that recently 
diverged from their Y gametologs would escape XCI, while genes that diverged from their Y 
gametologs far in the past would be completely X-inactivated. 
While it is likely that this “bug” model sufficiently explains some instances of XCI 
escape, it may also be true for a subset of XCI escapers that XCI escape or some corollary of 
escape is a biological “feature” that is a target of selection. For instance, XCI escape could result 
from dosage sensitivity, creating selective pressure to maintain biallelic expression of these 
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genes in females, or to maintain high expression in males and/or females. In these cases, we 
might see a greater degree of purifying selection on XCI escapers and their cis regulatory 
elements than on inactivated genes. Importantly, X inactivated genes might also be evolving 
under natural selection, but for different features: Assuming that biallelic expression is the 
ancestral state for an X chromosome gene, its cis regulatory sequences might need to undergo a 
period of positive selection or relaxed purifying selection in order to develop the ability to 
interact with the XCI machinery and undergo consistent silencing. 
If some genes indeed escape XCI as a consequence of functional constraints, they might 
show functional characteristics that are distinct from X-inactivated genes and independent of 
their physical location in the X chromosome. We can identify common functional characteristics 
of XCI escapers by comparing gene expression patterns, genetic and protein-protein interactions, 
biological process, cellular component annotations, and other features between XCI escapers and 
X inactivated genes. Pinpointing these features may provide valuable insight into the physical 
mechanisms of both XCI escape and XCI in humans and model organisms and clarify the roles 
of XCI escapers in human development and disease. In this dissertation, I describe my 
investigation of the relationship between XCI status and gene expression in humans, and 
comparisons of XCI profiles across four mammalian species, with the goal of elucidating some 
of these points. 
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CHAPTER 1 
GENE EXPRESSION AS A POTENTIAL DRIVER  
OF XCI ESCAPE EVOLUTION IN HUMANS 
 
Introduction 
The human XCI profile is the most extensive of any organism to date, with over 700 
genes having been assayed in at least one major study (Carrel and Willard 2005; Cotton et al. 
2015; Schultz et al. 2015). Human XCI escape also holds great interest to the medical genetics 
community due to its potential role in genetic disease and sex differences. As such, we chose to 
use publicly-available human XCI data sets to evaluate evidence for the “feature” model of XCI 
escape evolution, building on previous analyses by other groups that provided important 
preliminary evidence supporting this model. 
Park et al. (2010) were the first to examine this hypothesis by investigating the relative 
evolutionary rates of human XCI escapers compared to X-inactivated genes, using the Carrel and 
Willard 2005 XCI profile. By comparing protein coding DNA sequences of human X genes to 
the reference sequences of their one-to-one orthologs in Rhesus macaque and chimpanzee, they 
demonstrated that human XCI escapers show significantly lower evolutionary rate than 
consistently X-inactivated genes, indicating that they have experienced stronger purifying 
selection on average than X-inactivated genes. This pattern was most pronounced for the nine 
consistent XCI escapers that have retained a functional Y gametolog, and functionality of the Y 
gametolog was shown to be a strong predictor of an X gene’s XCI status. Later work by Bellott 
et al. (2014) showed that the set of eighteen X genes with functional Y gametologs across 
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mammals is extremely highly conserved within Mammalia, and shows enrichment for 
housekeeping functions such as transcription, translation, and protein modification. This finding 
raised the possibility that the signal of stronger purifying selection observed in human XCI 
escapers by Park et al. was primarily driven by this small group of ultra-conserved genes rather 
than being a general feature of XCI escapers. 
In addition to their observation of stronger sequence conservation in XCI escapers, Park 
et al. (2010) showed that human XCI escaper gene expression levels were more conserved across 
primates than those of X-inactivated genes. Expression level (Drummond et al. 2005; Wall et al. 
2005) and to a greater extent, expression breadth (Duret and Mouchiroud 2000; Park and Choi 
2010), are known to correlate strongly with nucleotide substitution rates in mammals, with 
highly, broadly expressed genes evolving more slowly than weakly-expressed or tissue-specific 
genes. Therefore, there is a strong possibility that gene expression level and/or breadth contribute 
to the high sequence conservation observed among XCI escapers. Importantly, this is a distinct 
hypothesis from that of selection on female-biased expression of XCI escapers resulting from 
XCI escape, which may contribute to sex-specific phenotypes (Trabzuni et al. 2013; Deng et al. 
2014). 
While previous studies have provided essential insights into the evolution of XCI, none 
have specifically focused on the relationship between purifying selection and gene expression 
across all XCI escapers compared to other X-linked genes. In order to investigate the possibility 
that gene expression patterns contribute to the differential signals of purifying selection between 
XCI escapers and X-inactivated genes, we used divergence data inferred from publicly available 
primate genomes, human polymorphism data, and human RNA-seq data to examine the 
relationship between purifying selection and gene expression within XCI categories (XCI 
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escapers vs. X-inactivated genes), controlling for Y gametolog functionality. We first separated 
genes with functional Y gametologs from the rest so that we could determine the extent to which 
the stronger signal of purifying selection in XCI escapers is dependent on the inclusion of these 
highly conserved genes. Then, we compared gene expression level and breadth across XCI and Y 
gametolog status combinations in females and males in multiple primary tissues. 
 
Results 
1. Composite human XCI profile 
In order to maximize the number of genes in our analysis, we assigned consensus XCI 
statuses to unique protein-coding X genes compiled from three studies that used different 
methods to determine XCI status: Carrel and Willard et al. (2005), Cotton et al. (2015), and 
Schultz et al. (2015). A summary of the assays and XCI classifications used in each study is 
shown in File S1.1, and XCI status calls in for all genes across all three studies are available in 
File S1.2. Based on the observation by Cotton et al. that most genes either primarily escape XCI 
or are inactivated across both tissues and individuals, we limited the number of XCI status 
categories within each data set to two – XCI escapers and X-inactivated genes – either by 
excluding variable (for Carrel and Willard 2005; Cotton et al. 2015) and tissue-specific (for 
Schultz et al. 2015) escapers, or by splitting these genes between the XCI escaper and X-
inactivated categories based on their behavior in the majority of individuals and/or tissues 
(details in File S1.2). We considered each data set individually, but also combined data across 
the three studies using a more inclusive definition of XCI escape. In this combined data set, we 
classified genes as XCI escapers if they showed significant evidence of escape in any number of 
tissues or individuals in any study. We classified all other genes as X-inactivated. This inclusive 
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definition left us with a list of 248 X genes that have been shown to escape XCI in at least one 
individual in one or more tissues in any data set, and 238 that were only X-inactivated in any 
data set. We report results for the combined data set throughout this chapter. 
2. Selection analysis 
For each XCI/Y status combination, we calculated two statistics derived from a 
McDonald-Kreitman (McDonald and Kreitman 1991) framework: N, the fraction of sites 
evolving neutrally, and S, the fraction of sites evolving under strong purifying selection (Mackay 
et al. 2012). Weak purifying selection and population expansion can both produce excesses of 
rare polymorphisms (Keinan and Clark 2012; Gao and Keinan 2014), which bias the McDonald-
Kreitman test. However, these statistics provide some differentiation between weak purifying 
selection and neutral polymorphism inflation, and all gene categories in this analysis are 
expected to share the same degree of neutral polymorphism inflation due to their shared history 
on X. We calculated the XCI escaper-to-X-inactivated ratios of S and N within each Y gametolog 
category by pooling polymorphism and divergence data across genes within each category, and 
resampling gene category membership with replacement 1000 times to account for variability in 
the extent of selection across genes. In cases where XCI escapers are undergoing more purifying 
selection than X-inactivated genes, these ratios are expected to be >1 for S and <1 for N. The 
three Y gametolog categories we considered were “functional Y” (the X gene has retained a 
functional, but not identical Y gametolog), “pseudogenized Y” (the X gene has a Y gametolog 
that is non-functional but detectable by sequence homology), and “lost Y” (no Y gametolog can 
be detected by sequence homology). There are a total of 15 genes in the functional Y gametolog 
category, 11 of which escape XCI and only 4 of which undergo X-inactivation, which severely 
limits the power of any statistical tests used to detect differences between them. However, the 
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direction of the relationship between XCI escapers and X-inactivated genes in this group is still 
somewhat informative, and in light of their high biological significance (Bellott et al. 2014) we 
report results for this class throughout this chapter. 
Using XCI status assignments from the combined data set, the S ratio was significantly 
greater than one and the N ratio was significantly less than one in all but the functional Y 
gametolog category (Figure 1.1; Table 1.1). To ensure that these results were not dependent on 
the inclusion of variable and/or tissue-specific XCI escapers, we calculated the same ratios either 
excluding or including variable and tissue-specific XCI escapers in each individual XCI status 
data set and in the combined data set. We observed that the S and N ratios were significantly 
greater and less than one (respectively) in at least one of the pseudogenized or lost Y gametolog 
categories in each XCI status data set. The S and N ratios for each XCI/Y category did not 
change significantly within each data set when variable and tissue-specific escapers were 
excluded (File S1.3). We also observed that S and N ratios were rarely significantly different 
between the categories of genes with pseudogenized and lost Y gametologs. Therefore, for the 
remainder of our analyses, we combined the pseudogenized and lost Y gametolog categories 
within each XCI category into a single “no Y” gametolog category. Combined, the results 
presented in this section show that the signal of stronger purifying selection in XCI escapers 
compared to X-inactivated genes 1) is evident across the different methods and definitions used 
to define XCI escape in each of the previous studies, 2) is not solely driven by XCI escapers with 
functional Y gametologs, and 3) is generally robust to the exclusion of variable or tissue-specific 
XCI escapers. 
 3. Contrasting gene expression patterns of XCI escapers and X-inactivated genes 
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Next, we sought to identify biological features that might drive constraint on XCI escaper 
evolution. Additionally, we wanted to evaluate the extent to which the trend of stronger 
expression level conservation among XCI escapers observed by Park et al. (2010) held when we 
included variable XCI escapers and genes with XCI status determined by methylation, which 
might include genes that were too weakly expressed to be assayed by allele-specific expression. 
To accomplish this, we used gene expression data from primary tissues across many individuals 
to compare expression level and breadth between XCI escapers and X-inactivated genes as 
classified in our combined XCI profile. We examined gene expression in both males and females 
because the gain in overall expression level produced by XCI escape is not necessarily very 
large. For instance, the Carrel and Willard (2005) data showed an average Xi to Xa expression 
level ratio among XCI escapers of approximately thirty percent. Furthermore, few human XCI 
escapers have been found to exhibit statistically significantly female-biased expression 
(Talebizadeh et al. 2013; Tukiainen et al. 2017). We therefore did not want to take for granted 
that XCI escapers would show expression differences between the sexes. 
 For our gene expression analysis, we used the publicly available NIH Genotype Tissue 
Expression (GTEx) data (v.4) (GTEx Consortium. 2015). This data set included RNA-seq data 
from multiple individuals of both sexes in twenty-three primary tissues taken from US tissue 
banks. We used data that had been converted to reads per kilobase per million (RPKM), which 
normalizes read count to transcript length to reduce bias towards long molecules (Mortazavi et 
al. 2008). To quantify gene expression breadth, we used the tissue specificity index τ (Yanai et 
al. 2005), defined in the methods section of this chapter. Highly tissue-specific genes will thus 
show high values of τ, whereas broadly expressed genes show low τ values. 
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In the early stages of our gene expression analysis, we observed that many X genes with 
non-zero expression values do not have any expression values over standard heuristic cutoffs, 
such as 1 RPKM. Given that our composite XCI profile included some XCI statuses determined 
based solely on methylation data, we chose to include weak expression values to ensure that 
these genes were not disregarded. To evaluate the effect of including weakly expressed X genes 
on our results, we ran each analysis using several different gene expression level cutoffs. First, 
we tried three commonly used fixed cutoff values: 1, 0.5, and 0.1 RPKM. Next, we adapted the 
method of Hart et al. (2013) to set expression level cutoffs that took into account the expression 
profile of each tissue. We set the minimum expression value for each tissue based on its 
distribution of X gene RPKM values across all individuals and used all expression values within 
some percentile of this distribution (one, two, and three standard deviations from the mean). We 
found that the general result of higher mean expression across XCI escapers compared to X-
inactivated genes was robust to the choice of minimum expression cutoff (Table 1.2), but more 
pronounced and significant with lower minima. We show expression results using the three 
standard deviation (3SD) expression cutoff in the remainder of this document. 
Using this definition of significant gene expression, we compared the expression of XCI 
escapers and X-inactivated genes across 23 broad tissue types in females and males separately 
using RNA-seq data from the GTEx Consortium (2015). We first obtained a single expression 
level value for each gene in each tissue by averaging significant expression values across 
individuals (see Methods) and observed that XCI escapers were generally more highly expressed 
than X-inactivated genes in individual tissues in both sexes (Figure 1.2.a). We then obtained a 
global expression value for each gene by taking the average of its expression values across 
tissues (Figure 1.2.b). To assess the significance of the differences between XCI escapers and X-
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inactivated genes at a global level, we calculated the average global expression value across 
genes in each XCI/Y category and calculated the XCI escaper-to-X-inactivated ratio of these 
values in each Y gametolog category. We permuted gene membership between the XCI groups 
in each Y gametolog category to obtain a p-value for this ratio. Within the no Y gametolog 
category, the XCI escaper global expression mean was significantly higher than the X-
inactivated global expression mean in both sexes. The XCI escaper-to-X-inactivated global 
expression mean ratio was 1.97 (p << 10-3) in females and 2.06 in males (p << 10-3). In the 
functional Y gametolog category, there was no significant difference between the global 
expression mean of significantly expressed X-inactivated genes and XCI escapers: the XCI 
escaper/X-inactivated global expression mean ratio was 0.867 (p = 0.529) in females and 1.204 
in males (p = 0.434). Data for this analysis is available in File S1.4 
Comparing the global expression ratios of XCI/Y categories across various minimum 
expression level cutoffs showed that the XCI escaper-to-X-inactivated global expression ratio 
was sensitive to the minimum expression cutoff. The purpose of using these filters was to avoid 
using RPKM values that are indistinguishable from background signal, but this results in a 
substantial loss of information in some XCI/Y categories (this is readily apparent in Figure 1.4, 
which is described in the expression breadth section of the Results). Therefore, to examine the 
impact of these weak expression values on global expression trends without making assumptions 
about what constitutes significant expression, we performed a non-parametric rank-based 
comparison of XCI/Y category expression. 
For each XCI/Y category, we obtained a single expression distribution by averaging 
unfiltered RPKM values (including zeros) across individuals for each gene in each tissue, 
resulting in a distribution of length n x 23, where n is the number of genes in the XCI/Y category 
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and 23 is the number of tissues. We then performed the Mann-Whitney U test to contrast the XCI 
escaper and X-inactivated RPKM distributions in each Y gametolog category. In females, the 
global Mann-Whitney U test p-values were 0.010 for XCI escapers > X-inactivated in the small 
functional Y gametolog category, and 2.2x10-16 for XCI escapers > X-inactivated in the much 
larger no Y gametolog category. In males, the XCI escapers > X-inactivated p-values were 0.047 
and 2.2x10-16 for the functional and no Y gametolog categories. This test highlights the fact that 
X-inactivated genes with functional Y gametologs are a unique group showing extremely weak 
expression in many tissues but unusually high expression in others, whereas the XCI escapers 
with functional Y gametologs are more uniformly highly expressed. These results further support 
our overall conclusion that XCI escapers tend to be more highly expressed than X-inactivated 
genes. 
To compare expression breadth between XCI categories, we calculated the tissue 
specificity index τ (Yanai et al. 2005; Methods) for each gene and compared its distribution 
between XCI categories. XCI escapers showed significantly lower values τ of than X-inactivated 
genes in both sexes and in both Y gametolog categories (Figure 1.3; Table 1.3), indicating that 
they are more broadly expressed than X-inactivated genes. As an additional expression breadth 
measurement, we calculated the proportion of tissues for which each gene showed significant 
expression (Methods) and observed that XCI escapers were significantly expressed in a higher 
proportion of tissues than X-inactivated genes with the same Y gametolog status in both sexes 
(Figure 1.4, File S1.6). Consistent with previous work demonstrating that XCI escapers with 
functional Y gametologs are enriched for highly conserved functions (Bellott et al. 2014), these 
genes showed the lowest τ values in both sexes across all XCI/Y categories. 
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Conclusions 
In this work, we have collected and analyzed data from three of the most recent and 
comprehensive studies with information on human XCI escape. The results of our selection 
analysis are consistent with the hypothesis that XCI escape or some corollary of it is under 
evolutionary constraint. However, they do not constitute direct evidence for the “feature” model 
of XCI escape being a general rule. Our gene expression analysis results suggest that expression 
level and breadth might contribute to this signal of purifying selection, but they do not clarify the 
nature of the relationship between XCI status and expression. We can broadly characterize this 
relationship according to two distinct, but not mutually exclusive models.  
First, XCI escape itself might be the target of purifying selection. One possibility is that 
the female expression bias produced by expression of the Xi allele in females is functionally 
important in normal development. Perhaps the strongest support for this model comes from 
studies of X aneuploidy syndromes such as Turner syndrome (45, X) and Kleinfelter syndrome 
(47, XXY). For instance, reduced expression of several human XCI escapers in individuals with 
Turner syndrome has been implicated in phenotypes associated with this disorder, including 
ovarian failure, heart defects, and various neurological abnormalities (Ellison et al. 1997; Bione 
et al. 1998; Zinn and Ross 1998). Another study identified several XCI escapers that were 
inferred to be highly dosage-sensitive to be promising candidates for various X aneuploidy 
syndromes (Pessia et al. 2012). However, the rarity of significant female expression biases 
introduced by XCI escape makes this model a poor fit for the majority of XCI escapers. For 
instance, in one study, only fifteen ChrX genes surveyed showed significant female expression 
biases in at least one of eleven human tissues, and only six of these escape XCI (Talebizadeh et 
al. 2006). In a recent study that also used the GTEx expression data and a more sensitive 
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definition of sex biased expression, sixty XCI escapers exhibited female-biased expression and 
several others showed male-biased expression in some tissues (Tukiainen et al 2017). 
Alternatively, XCI escape may be an indirect consequence, rather than a driver, of gene 
expression patterns via any of a number of molecular mechanisms, such as local perturbations in 
chromatin state. For instance, inefficient silencing of strong promoters or other cis regulatory 
elements prior to or during XCI could prevent these genes from undergoing complete silencing 
(Brown and Greally 2003; Migeon 2014). It is now well-established that XCI escapers co-
localize with each other outside of the Barr body in three-dimensional space, producing 
topologically associated domains that are clearly distinct from the rest of the chromosome in 
both human and mouse (Lieberman-Aiden et al. 2009; Splinter et al. 2011; Engreitz et al. 2013; 
Deng et al. 2015; Giorgetti et al. 2016). There is also some evidence in mouse that XCI escapers 
are more highly expressed than X-inactivated genes early in development (Marks et al. 2015), 
but it is unknown if this also occurs in humans. However, the observation that human genes 
escaping XCI in females are more highly expressed than X-inactivated genes in adult tissues 
from both males and females is consistent with this model, as cis regulatory elements would be 
shared between the sexes. Similarly, Cotton et al. (2015) observed that monozygotic twins are 
much more likely to show the same XCI status at variable escape genes than is expected by 
chance.  
Importantly, there are several limitations in our study. First, only approximately two 
thirds of the human X chromosome genes had an XCI status assignment in one or more of the 
three data sets used in this study. As such, the observations we have made about selection 
patterns and gene expression must be continuously revaluated as the human XCI profile is 
extended. Second, we cannot definitively say that the XCI statuses we have assigned to these 
 20 
genes generalize to the broader population and/or other primary tissues. The true extent of 
variation in XCI profiles is still unknown and will require expanding the number of tissues and 
individuals in studies of XCI status. In particular, our results highlight the variability and 
uncertainty in the definition of variable XCI escapers, which were often annotated as variable 
escapers in one data set and as consistently escaping or X-inactivated in one of the others (Table 
S2). We suggest that it should be a priority to determine whether variable escape reflects true 
polymorphism for underlying mechanistic differences among individuals in escape status, or 
whether it is technical noise that arises from catching the tail of a distribution of allele-specific 
expression or methylation after studying sufficiently many samples across sufficiently many 
tissues. 
Finally, it is important to note that our result of higher and broader gene expression 
among XCI escapers compared to X-inactivated genes (but not the purifying selection results; 
Table 3) is dependent on the inclusion of many weakly-expressed genes that have typically been 
excluded from XCI and gene expression studies (as described in Results section 3), and the 
inclusion of the genes with XCI statuses derived from the Schultz et al. 2015 study: if these are 
excluded from the analysis, the mean expression level and breadth of the X-inactivated genes is 
not significantly different from the XCI escapers. Schultz et al. determined the criteria for calling 
a gene X-inactivated or escaping XCI from sex-biased mCH levels based in part on the ability of 
these criteria to recapitulate the XCI status assignments generated by ASE in Carrel and Willard 
2005 for genes assayed in both studies. While we have no reason to distrust the Schultz et al. 
XCI assignments for this reason, it would be prudent to cross validate them in additional samples 
and perhaps using other methods. Because is likely that many of these genes could not be 
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assayed by ASE due to either weak gene expression or lack of informative SNPs, these other 
methods might include other types of epigenetic marks, or chromatin conformation capture. 
Overall, we concur with many previous studies that human XCI escapers are promising 
candidates for investigation as contributing to human genetic disorders that exhibit significant 
sex differences in incidence, severity, or symptoms, as well as those that show high phenotypic 
variability among females. In particular, large-scale disease studies are likely to benefit from 
incorporating information about a gene’s XCI status in association analyses, as in Tukiainen et 
al. (2014), Chang et al. (2014), and Ma et al. (2015).  
 
Methods 
1. Combining XCI profiles across studies 
We obtained XCI statuses for 758 unique protein-coding human X loci from three data 
sets: Carrel and Willard (2005), Cotton et al. (2015), and Schultz et al. (2015) (File S1.2). These 
XCI statuses were determined based on allele-specific expression from the inactivated X (Carrel 
and Willard 2005), female versus male transcription start site CG dinucleotide (mCG) level 
(Cotton et al. 2015), and female versus male gene body non-CG methylation (mCH) level 
(Schultz et al. 2015). Brief descriptions of the assays and categorizations used in each study are 
shown in File S1.1. 
To ascertain the effects of the different methods of determining XCI status and the impact 
of variable and tissue-specific XCI escapers on the overall patterns of purifying selection across 
XCI categories, we repeated the analysis of strong purifying selection (described below) in each 
individual data set. For the two data sets with information about heterogeneous/variable escape, 
we performed these calculations either excluding variable escapers or splitting them into the 
 22 
consistent escape and consistently X-inactivated categories. For the Schultz et al. data set, we 
calculated these statistics using the set of genes that escaped in any of eleven tissues as XCI 
escapers, and using only genes that escaped in six or more tissues as escapers (treating those that 
escaped in five or fewer tissues as X-inactivated). We observed that excluding variable or tissue-
specific escapers did not result in a significant change in the results within the individual data 
sets, nor did it have a significant effect on the “combined” data set defined by aggregating XCI 
statuses across all three studies using an inclusive definition of XCI escape: all genes showing 
escape in any number of tissues and/or individuals in any study were considered XCI escapers, 
and all others were considered X-inactivated (File S1.2). This definition of XCI is expressly 
somewhat more inclusive, and meant as an appropriate contrast, being less vulnerable to false 
negatives in the identification of XCI escape associated to the nuances of the particular methods 
used in each of the individual studies. 
2. Polymorphism data 
For our polymorphism analyses, we took advantage of a large, high-depth whole-exome 
sequence data set from the NHLBI GO Exome Sequencing Project (ESP), which includes a large 
amount of rare (minor allele frequency<0.5%) single nucleotide variants (SNVs) (Fu et al. 2013). 
We included only biallelic variants in the European American subsample with an average 
sequencing depth >20X, and that passed the original (Tennessen et al. 2012) quality control 
filters. The number of copies n available in the ESP data set varies across SNVs, with a range of 
2379-6728, a mean of 6558, and a standard error of the mean of 2.51 across non-PAR X sites. To 
make all sites comparable, we down-sampled derived allele counts at each site to a total of 6056 
(90% of the maximum n value), according to the method described in Marth et al. (2004), and 
excluded variants for which data were available for fewer than 6056 copies.  
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3. Divergence data 
To facilitate expression analyses (described below), we considered only the transcript 
with the greatest total exonic length in the RefSeq database for each unique protein-coding gene, 
yielding 748 non-overlapping X transcripts. Of the 1,048,661 unique ESP SNVs across the entire 
human exome, 24,795 were associated with these 748 transcripts, with the majority falling in 
non-exonic regions. Polymorphic, divergent and conserved monomorphic sites were identified as 
either synonymous (Syn) or non-synonymous (NonSyn) based on the genetic code. Counts of 
divergent and polymorphic sites were calculated for each transcript. Divergent sites were those 
for which the human reference (hg19) allele differed from the ancestral allele, inferred by the 
reference chimpanzee (panTro4) allele and confirmed by one or both of the reference orangutan 
(ponAbe2) and macaque (rheMac3) alleles. Sites for which the ancestral state could not be 
confirmed in this manner were excluded. 
4. Quantifying ancient/strong purifying selection via polymorphism and divergence 
Transcripts were filtered to remove overlap with annotated segmental duplications, 
repetitive elements or ampliconic regions, as well as potential CpG dinucleotides (in either the 
ancestral or derived state) and sites with uncertain ancestral states resulting from poor synteny as 
defined by the UCSC syntenic net tracks, or ambiguous ancestral state (as defined above). After 
filtering, we were left with 525 X transcripts that retained at least one exon with usable data, 
existed in a single-copy, and were inferred to be present on the ancestral mammalian X. These 
525 loci were the final set of genes we considered in our analysis. Across these genes, there were 
3,581 NonSyn polymorphic sites, 2,279 Syn polymorphic sites, 392 NonSyn divergent sites, 558 
Syn divergent sites, 1,431,973 conserved NonSyn sites, and 507,404 conserved Syn sites. All site 
counts for each gene are available in File S1.7. 
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The McDonald-Kreitman (MK) test (McDonald and Kreitman 1991) uses the ratios of 
selected and neutral sites among intra-species polymorphisms compared to inter-species 
divergences to detect departures from neutral evolution. We used non-synonymous (NonSyn) 
and synonymous (Syn) sites of protein-coding genes as our selected and neutral site classes, 
respectively, and calculated three statistics based on the MK test across XCI/Y categories. In 
these statistics,  and  are the Syn and NonSyn conserved (monomorphic) site counts, 
respectively.  and are the neutral and weakly deleterious fraction of polymorphic 
sites out of  NonSyn polymorphisms overall. These are estimated by partitioning the NonSyn 
and Syn polymorphic site counts  and  into arbitrarily defined bins of high and low derived 
allele frequency, and using the neutral low:high count ratio to calculate the expected fractions of 
the rarest selected polymorphisms that are weakly deleterious and neutral. Throughout this study, 
we report values calculated using a derived allele frequency cutoff of >1% to classify SNVs as 
high frequency, which corresponded to a down-sampled derived allele count of 61. For a more 
detailed description of the calculation of these statistics, refer to the supplementary material of 
Mackay et al. (2012). The statistics we calculated for each XCI/Y group were: 
, the fraction of sites that are neutral (called f in Mackay et al. 2012); 
, the fraction of sites that are evolving under weak purifying selection 
(called b in Mackay et al. 2012); and , the fraction of sites evolving under 
strong purifying selection (called d in Mackay et al. 2012).  The fraction of sites that are weakly 
deleterious, W, was the only statistic for which the relationships between XCI/Y categories 
changed across cutoff DAFs (File S1.8). However, because W was an order of magnitude smaller 
than either N or S in all categories, we concluded that these fluctuations are most likely due to 
chance, and we did not further analyze this statistic. 
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5. Y gametolog status data 
Y gametolog statuses for 723 unique protein-coding X genes were obtained from Wilson-
Sayres and Makova (2013), who identified Y gametologs based on interspecies comparisons and 
human X/Y homology. The Y gametolog categories described in this study were defined as 
follows: 594 genes that were inferred to be ancestral in the eutherian lineage (conserved across 4 
species among the set including mouse, rat, rabbit, cow, horse, dog, opossum and chicken) were 
classified as “Functional Y” (n = 19), “Pseudogenized Y” (n = 265), and “Lost Y” (n = 312). 
Finally, we removed three genes located in the human-specific X-transposed region from 
consideration, of which two had functional Y gametologs and one had a pseudogenized Y 
gametolog. For some analyses, based on our initial results, we combined the two categories of 
“Pseudogenized Y” and “Lost Y” into a single category, “no Y” corresponding to no functional 
Y gametolog (see Results).  
6. X gene copy number data 
Human X gene copy classifications were obtained from Mueller et al. (2013). In this data 
set, genes were annotated as single-copy, X multicopy or ampliconic, where X multicopy genes 
had at least one cis paralog but were not in ampliconic regions, and ampliconic genes were those 
in or near ampliconic regions. Because ampliconic and multicopy genes are poorly conserved 
across the great apes, we only considered in this study genes with a single copy on the human X. 
7. Gene expression data filtering 
To assess differences in human gene expression across XCI/Y categories, we used the 
publicly available NIH Genotype-Tissue Expression (GTEx) RNA-seq data set (GTEx 
Consortium 2015), which includes expression data in 51 primary tissue subtypes across 30 broad 
tissue types from American women (78) and men (138). Many genes in certain XCI/Y categories 
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are very weakly expressed, and retain no usable data if we use typical arbitrary minimum 
expression values (e.g. 1 RPKM) to remove potentially spurious measurements from the RNA-
seq data. However, these weakly expressed genes are not typically statistical outliers in the 
expression distributions of their gene categories. We therefore elected to use an adaptive method 
for filtering background expression values in an unbiased manner while including low expression 
values that were not outliers. For each broad tissue type, we fit a half Gaussian distribution to the 
higher mode of the distribution of non-zero log2(RPKM) values across all individuals for all X 
genes, and mirrored it to capture the expression distribution of actively transcribed genes (Hart et 
al. 2013). We then used three standard deviations below the means of these distributions as a 
minimum expression value to consider a gene significantly expressed in each tissue, while 
excluding the other genes from analysis. The sex- and tissue-specific expression cutoffs defined 
in this way are available in File S1.9. After individual expression values were filtered according 
to these minima, the remaining values were averaged across 1000 bootstrap samples of 
individuals for each gene in each tissue. For the sake of clarity, in this section we refer to each 
gene’s average expression across individuals in each tissue as its expression value for that tissue. 
8. Gene expression level analysis 
For GTEx tissues with multiple subtypes, we considered only the subtype with the largest 
sample size, yielding one expression value for each broad tissue type for each gene. To ensure 
that all genes had data for equal numbers of tissues in females and males, we excluded sex-
specific tissues (cervix, fallopian tube, ovary, uterus, vagina, prostate, and testis) from our 
expression analyses, leaving 23 broad tissue types in both sexes. The mean expression values 
across all tissues for each gene are available in File S1.4 and displayed in Figure 1.2.b. For each 
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tissue, we also calculated the mean and standard deviation of global expression values across 
each XCI/Y category. These data are shown in Figure 1.2.a. and are available in File S1.4. 
To assess the significance of global expression ratios between XCI escapers and X-
inactivated genes in each Y gametolog category, we performed 1000 permutations of gene 
membership in pairs of XCI/Y groups and calculated the difference in the mean expression of 
these genes across all tissues. P-values reflect the proportion of permutations for which the ratio 
of average expression values between categories, averaged across all tissues, was greater than or 
equal to the observed. Repeating this analysis using various more and less lenient fixed and 
adaptive expression minima showed that the adaptive three standard deviation threshold 
produced results that were closest to those generated using a fixed threshold of 0.1 RPKM 
(Figure S4), which is the same threshold used by the GTEx Consortium in their own expression 
analyses (GTEx Consortium 2015) and similar to the threshold value calculated by the analysis 
of Hart et al. (2013). 
To calculate two-sided Mann-Whitney U test statistics and p-values for the unfiltered 
expression distributions in each Y gametolog category in each sex, we first calculated the 
average RPKM values for each gene in each tissue across individuals. These values were pooled 
across genes and tissues in each XCI/Y category, and the test then applied for each pair of these 
pooled data sets using the wilcox.test function for unpaired data in R.  
9. Gene expression breadth analysis 
We calculated the tissue-specificity index τ (Yanai et al. 2005) for each gene to quantify 
the breadth of expression across each category (data available in File S1.5). This statistic is 
defined for each gene as:  
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where N is the number of tissues and xi is the expression value of this gene in tissue i, normalized 
by its maximum expression value across all N tissues. High values of this statistic (e.g. >0.6) 
indicate that the gene’s expression is skewed towards a small number of tissues, and low values 
indicate that it is expressed at similar levels across many tissues. Based on the expression data 
described in the previous subsection, the genes in each XCI/Y category were resampled with 
replacement 1000 times, and the mean and standard deviation of the τ values across these 
resamples were obtained (Table 1.2).  
 Lastly, for each gene, we calculated the proportion of 23 broad tissue types for which it 
showed significant expression (greater than the minimum expression value for each tissue, 
defined as in the previous section) as an additional metric of expression breadth (Figure 1.4). The 
gene membership of each XCI/Y category was resampled with replacement 1000 times and used 
to compute the mean and standard deviation (Table 1.3). 
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CHAPTER 2 
PRELIMINARY CANINE XCI PROFILE  
FROM SINGLE-CELL RNA-SEQ 
 
Introduction 
 
Despite high sequence conservation of X chromosome genes among mammals, XCI 
profiles differ substantially across the three species for which extensive profiles have been 
ascertained (Wang et al. 2014; Cotton et al. 2015; Berletch et al. 2016; Supplementary 
Materials). This suggests that XCI profiles may have evolved in a largely lineage-specific 
manner within the mammalian clade. Given the history of the therian sex chromosomes, this is 
likely: These chromosomes appear to have originated from an autosomal pair in the therian most 
recent common ancestor and show strong sequence homology to the avian chromosomes 1 and 4. 
Divergence between the therian X and Y chromosome was likely driven by the translocation of 
the testis-determining gene SRY from an ancestral sex chromosome to the proto-Y chromosome, 
followed by a breakdown of recombination between X and Y as the Y accumulated large-scale 
structural rearrangements (Charlesworth 1991). This eventually resulted in the pseudogenization 
or loss of many Y chromosome genes, and XCI of the corresponding X genes is believed to have 
evolved in a stepwise-manner to compensate for the resulting dosage differences between males 
and females (Jegalian and Page 1998). This model is supported by the high correlation between 
the functionality of Y genes and the XCI status of their X gametologs within species (Jegalian 
and Page 1998; Wilson-Sayres and Makova 2013). 
Given that the extent of X and Y divergence differs widely across mammals, (Raudsepp 
and Chowdhury 2015), it follows that XCI profiles would also differ between species. However, 
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if some selective pressure drives certain genes to escape XCI or be inactivated independent of 
their Y gametolog status, these genes might share an inactivation status across species despite 
having different evolutionary histories. Therefore, cross-species comparisons of XCI profiles can 
improve our understanding of the evolutionary drivers and consequences of XCI and XCI escape 
within and across mammals. 
An analysis of this type would ideally include complete XCI profiles from a wide range 
of mammalian species, from the most basal to the most derived. While individual genes have 
been assayed by immunofluorescence (Chaumeil et al. 2011; Al Nadaf et al. 2012), quantitative 
PCR (Yen et al. 2007), or methylation patterns (Bell et al. 2008) in several species, large-scale 
XCI profiles are available for only three species at present: human (Carrel and Willard 2005; 
Cotton et al. 2015; Schultz et al. 2015), mouse (M. musculus) (Yang et al. 2010; Berletch et al. 
2015), and opossum (M. domestica) (Wang et al. 2014). The difficulty in ascertaining such XCI 
profiles arises from female tissue mosaicism with regards to the active X homolog. Specifically, 
most tissues contain a mixture of cells expressing the maternal or paternal X homolog, 
complicating allele-specific expression (ASE) analysis from bulk tissue samples. In light of this, 
past studies of XCI have typically been confined to artificial hybrid cell systems (Carrel and 
Willard 2005) or rare tissue samples with highly skewed XCI patterns (Cotton et al. 2013), 
which is uncommon in karyotypically normal adult tissues (Amos-Landgraf et al. 2006). 
The development of high-throughput single-cell RNA-sequencing (scRNA-seq) 
technology presents a novel opportunity to acquire cell-specific XCI status calls from primary 
cell populations, as recently implemented in human peripheral blood mononuclear cells 
(PBMCs) (Tukiainen et al. 2017). Several scRNA-seq platforms are currently available, but all 
use a general strategy of capturing and lysing individual cells, reverse transcription of their 
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mRNA, cDNA amplification, library construction, and sequencing (Liu and Trapnell 2016). 
More recently, some systems have incorporated unique molecular identifier (UMI) sequences, 
which barcode individual RNA molecules during the reverse transcription step. This enables 
direct transcript quantification, which produces precise ASE information from small amounts of 
starting material. 
However, even with scRNA-seq, the number of genes that can be profiled in an ASE 
experiment is limited by the degree of heterozygosity of the cell sample donors at loci of interest. 
In non-human subjects, this limitation can be addressed by using species- or breed-hybrid 
individuals, which are more likely to carry distinct maternal and paternal alleles for any given 
locus. For instance, Wang et al. (2012) used horse-donkey hybrids (mules and hinnies) to 
facilitate ASE analysis to assess imprinting status. The domestic dog (C. lupus familiaris) 
presents an excellent opportunity to apply this strategy to XCI profiling, as intensive breeding 
over the past two centuries has produced extensive between-breed population structure 
(Vonholdt et al. 2010) and within-breed homozygosity (Boyko et al. 2010; Shannon et al. 2015). 
With this in mind, we sampled two individuals of one of the more common breed hybrids, the 
“goldendoodle” (a golden retriever-poodle hybrid), and performed X chromosome-wide XCI 
profiling using scRNA-seq. A carnivore XCI profile is particularly useful for studying the 
evolution of XCI escape because the carnivore X and Y are less diverged than in human and 
mouse, with a 6.6Mb PAR, and compared to the rodent X, the canine X has experienced fewer 
large-scale structural rearrangements relative to the human X (Federici et al. 2015). Therefore, 
comparing the human and canine XCI profile may produce novel insights into the roles of 
divergence from Y versus gene identity in determining XCI status. To this end, we use this XCI 
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profile in a comparison of XCI profiles a comparative study of XCI profile evolution across 
mammals in the next chapter of this dissertation. 
Results 
1. Genotyping 
Two adult female F1 goldendoodles, hereafter referred to as Dog1 and Dog2, were 
genotyped using the Embark Veterinary custom Illumina CanineHD array. The two dogs 
represented both cross directions: Dog1’s father was a golden retriever and its mother was a 
standard poodle, while Dog2’s father was a standard poodle and its mother was a golden 
retriever (pedigree shown in Figure 2.1). The genotypes of the dogs were concordant with the 
parental breeds and cross generation specified by their pedigrees. The array includes 6,030 
markers on X (chromosome 39). 1,388 and 1,693 of these sites were heterozygous and therefore 
informative for ASE analysis in Dog1 and Dog2, respectively, giving a total of 2,404 unique 
informative X sites. 
2. Single-cell RNA sequencing 
Single-cell RNA sequencing (scRNA-seq) was performed on peripheral blood 
mononuclear cells (PBMCs) from each dog using the 10X Genomics Chromium platform to 
generate bar-coded single-cell Illumina RNA sequencing libraries, which include both cell-
specific barcodes and UMIs. Barcoded cDNAs were then sequenced with the Illumina Next-Seq 
500 instrument. Raw sequencing output was pre-processed to demultiplex reads by cell and 
transcript, and to remove adapter sequences. Trimmed reads were then mapped to the canine 
reference genome (canFam3.1), and PCR duplicates were removed. Following these steps, the 
Dog1 and Dog2 samples produced, respectively: 1,234 and 991 cells, with 213,010,866 and 
209,833,555 total reads, and 172,618 and 211,739 mean reads per cell. 
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The program FASTQC (Andrews et al. 2010) was run on the raw aggregate alignment 
file for each sample and used to calculate per-base sequence quality, per sequence quality scores, 
and duplication levels. Based on these results, we removed non-primary alignment reads, which 
reduced estimated duplication levels to approximately 25 and 29% for Dog1 and Dog2, 
respectively. 
As an additional assessment of the quality of our scRNA-seq data, we identified PBMC 
subpopulations using the cell clustering workflow developed by Satija et al. (2015), which 
groups cells by their expression profiles using a K-nearest neighbors strategy and identifies the 
most highly differentially-expressed genes in each group. As expected, the observed cell clusters 
derived from gene counts corresponded to known PBMC subtypes, including monocytes, T cells, 
B cells, and granulocytes. All but one population in the Dog2 sample could be identified based 
its top ten cluster marker genes. Cell populations in both samples are shown in Figure 2.2, and 
the workflow steps and outputs can be found in File S2.1. 
To confirm that it was possible to effectively differentiate between mono- and biallelic 
expression at the cell level using our scRNA-seq read data, we used the Integrative Genome 
Viewer (IGV) software package (Robinson et al. 2011) to examine raw read data at genes with 
XCI statuses that we are reasonably certain of that also showed evidence of containing 
heterozygous sites in our data. We show images of raw read data in single cells for two examples 
genes in Figure 2.3. The first, Xist (ENSCAFT00000048497 and ENSCAFT00000045197 in 
canFam3.1), is expected to show completely monoallelic expression, as it is the non-coding RNA 
that mediates XCI through exclusive expression from the Xi. The second, ARSE 
(ENSCAFG00000025078), is located well within the canine PAR at ~1.5Mbp and is therefore 
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expected to show expression from both the Xa and Xi. Although the raw reads at these genes 
show some error, they are consistent with these expectations. 
 
3. XCI profile 
 
 To determine the XCI status of canine genes from our scRNA-seq data, we first identified 
heterozygous sites in each dog from their SNP array genotypes and filtered scRNA-seq data. 
After identifying these sites, we called each site in each cell as showing either bi- or monoallelic 
expression within that cell. These calls were then combined across sites within the same gene to 
get a gene-level expression pattern call in each cell. Genes that showed biallelic expression in 
two or more cells within a single dog were called as XCI escapers in that dog, while the 
remaining genes that showed monoallelic expression in at least one cell were called as X-
inactivated in that dog. A full description of the methods used to make these calls is available in 
the Methods section of this chapter, and the workflow steps and outputs are shown in File S2.2. 
 In total, we obtained an XCI status call for 152 genes across the two dogs (available in 
File S2.5). Of these, 143 were in the X-specific region of the chromosome, and 9 were in the 
PAR. Of the non-PAR genes, 21 were observed to escape XCI in both dogs, 9 showed variable 
XCI escape (i.e. escaped in one dog and were inactivated in the other), 15 escaped XCI in one 
dog and were uninformative in the other, 24 were X-inactivated in both dogs, and 74 were 
inactivated in one dog and were uninformative in the other. In total, 45/143 (31%) non-PAR 
genes tested were observed to escape XCI in at least one dog. The gene-level minor allele 
frequency for each cell and the consensus XCI status for each informative gene is shown in 
Figure 2.5. 
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Lastly, we compared our XCI status calls to previously reported canine XCI statuses for 
two informative non-PAR X genes: COL4A5 (ENSCAFG00000018020), which was reported as 
X-inactivated by Bell et al. 2008, and CHM (ENSCAFG00000017406), which was reported as 
escaping XCI by Chase et al. 2005. Our results showed that COL4A5 escaped XCI in both dogs 
and that CHM was inactivated in one dog and uninformative in the other. This discordance may 
be explained by fixed genetic differences between breeds (the breeds used in Bell et al. 2008 and 
Chase et al. 2005 were Navasota dog and Portuguese water dog). Additionally, it is possible that 
the different results in our study are a consequence of using a different tissue type than either of 
the previous studies. Tissue-specific XCI escape has been observed in both human (Cotton et al. 
2015) and mouse (Berletch et al. 2015), and certain naïve lymphocytes have been suggested to 
be particularly prone to partial reactivation of some X-linked immune genes in mouse and human 
(Wang et al. 2016), causing higher rates of XCI escape than is observed in other cell types. 
However, a recent study of human XCI using scRNA-seq in whole blood samples found high 
concordance between their XCI profile and those derived from other tissue types (Tukiainen et 
al. 2017). Moreover, neither CHM nor COL4A5 are known to have immune functions in either 
humans or dogs. 
 
Conclusions 
 
In this chapter, we describe a preliminary XCI profile for the domestic dog derived from 
scRNA-seq of PBMCs from two F1 crossbreed dogs. It consists of 143 non-PAR X chromosome 
genes, with 45 escaping XCI in one or both dogs. This represents the first ever carnivore XCI 
profile, and the second XCI profile generated from scRNA-seq. It is comparable in size to the 
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human XCI profile generated from scRNA-seq by Tukiainen et al. (2017), which included a total 
of 165 genes across 4 samples. 
While this analysis represents an important first step in investigating XCI in dogs, its 
methodology and small sample size limits the extent to which our findings can be generalized. 
The low coverage inherent to scRNA-seq data precluded analysis of weakly- but potentially 
significantly- expressed genes, which might be testable by epigenetic marks as in Wang et al. 
2014, Cotton et al. 2015, and Shultz et al. 2015. Moreover, sampling bias caused by low mRNA 
capture efficiency in scRNA-seq severely restricted our ability to detect biallelic expression even 
in cases where the expected allelic ratio was approximately 50:50. For example, of the 9 PAR 
genes with XCI status calls, only 3 were called as XCI escapers. Consequently, while we are 
confident that the genes we have called as XCI escapers genuinely are expressed from both X 
chromosomes in these samples, there is less evidence to suggest that genes called as X-
inactivated are actually consistently inactivated. Further, without genome sequence data from 
these individuals, we were forced to conservatively identify ASE-informative sites and 
consequently may have missed some heterozygous sites. Finally, lacking information about the 
parental genotypes to phase the X chromosomes in our samples, we likely missed some cases of 
apparent monoallelic expression of the Xi allele caused by sampling bias, which would be 
consistent with XCI escape. In light of these limitations, it would be prudent to independently 
validate the XCI statuses identified in this study with a more sensitive method of assessing ASE, 
such as allele-specific pyrosequencing. 
With samples of a single cell type in only two individuals, we did not have the ability to 
assess the extent of variation in XCI escape across individuals that has been observed in humans 
(Cotton et al. 2015; Shultz et al. 2016). We suggest that future studies include more individuals, 
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possibly from crosses of more deeply diverged breeds to increase the number of testable genes. 
Analyzing additional cell and tissues types within individuals would also be informative. In 
particular, it would be interesting to examine expression of X genes in placental tissues to 
ascertain whether or not dogs show paternal XCI in these tissues as in marsupials and several 
placental mammals (Wang et al. 2014). 
Of great interest to our group is how similar the dog XCI profile is to other mammalian 
XCI profiles. Our dog XCI profile shows more XCI escapers (45) than mouse (38) and opossum 
(24), but less than a third of the number of human XCI escapers (over 200, depending on the 
exact definition used). Assuming that most of the ~1200 remaining dog X chromosome genes are 
X inactivated, a substantially lower fraction of X chromosome genes (~4%) escape in dog 
compared to at least 23% in human (Tukiainen et al. 2017). This is somewhat surprising given 
that the dog X and Y chromosomes are substantially less diverged than the human X and Y 
chromosomes, potentially suggesting that dog X genes might have evolved the ability to be X-
inactivated more rapidly than human X genes. However, with analysis of more dogs/tissues and 
using more sensitive methods, more XCI escapers may eventually be identified. We expand on 
interspecies comparisons of XCI profiles in the next chapter of this dissertation. 
 
Methods 
1. PBMC scRNA-seq 
We drew a single ~10 milliliter (mL) whole venous blood sample from each of two adult 
female F1 goldendoodles, i.e. the first-generation offspring of a purebred golden retriever and 
purebred standard poodle. Breed composition was confirmed by pedigree records and breed mix 
inference based on SNPs. These two individuals represented both directions of this cross: Dog1 
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was the daughter of a female standard poodle and male golden retriever, and Dog2 was the 
daughter of a female golden retriever and a male standard poodle. Having both cross directions 
allows us to differentiate between allele-specific expression caused by XCI and parent of origin 
effects. Blood samples were collected in 12 mL EDTA tubes and stored on ice for 2.5 hours 
before being processed according to the protocol of Viana et al. 2013: Blood samples were 
placed in a mixture of Ficoll–Hypaque (Sigma Chemical Co., USA, density: 1.119 g/mL) and 
Ficoll–Hypaque (Sigma Chemical Co., USA, density: 1.077 g/mL) at a 1:3 ratio (Ficoll/blood) in 
sterile polystyrene conical bottom tubes (Falcon™, Corning ®, USA). Samples were centrifuged 
at 700 × g for 80 min at 22 °C. The ring of mononuclear cells collected at the Ficoll–Hypaque 
interface was transferred to another tube with 40 mL of Falcon sterile 1× PBS containing 10% 
FBS. This tube was centrifuged two times at 400 × g for 10 min at 4 °C. After the supernatant 
was discarded, the cells were resuspended in 1 mL of cell culture medium RPMI 1640. Cells 
were counted in a Neubauer hemocytometer chamber to determine the numbers of cells and were 
diluted a concentration of 1 million cells per mL.  
Using the 10x Genomics Chromium platform, these cells were combined with 10x 
Genomics v1 chemistry 3’ Single Cell library reagents for reverse transcription to generate 
150bp cDNAs with UMIs and cell-specific barcodes. The cells were then combined and lysed, 
and cDNAs were amplified using polymerase chain reaction (PCR). Dual-index paired-end 
sequencing of amplified cDNA was performed on the Illumina NextSeq500 platform according 
to the protocol recommended by the manufacturer. 
2. Processing and filtering scRNA-seq data 
The raw RNA-seq read data was processed with the 10x Genomics software CellRanger 
2.0.2 to obtain cell-specific expression data. First, the pipeline mkfastq was used to demultiplex 
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the raw Illumina reads, producing FATSQ files for each sample containing all reads across all 
cells. These were used as input to the cellranger count pipeline, which separated reads according 
to their cell and molecule barcodes, trimmed barcode and adapter sequences, and used STAR 
(Dobin et al. 2013) to perform read alignment to the canFam3.1 reference genome. This pipeline 
also performed filtering to remove PCR duplicates and generated a unique molecular identifier 
(UMI) count for each gene in each cell.  
To identify the blood cell subpopulations represented in each sample, we used the R 
package Seurat v2.0 (Satija et al., 2015) and the suggested guided clustering workflow 
(http://satijalab.org/seurat/pbmc3k_tutorial.html). We first removed cells that were outliers in 
terms of their percent mitochondrial RNA content and total number of detected genes. Next, we 
identified the top ~2500 most variable genes across each sample to use for cell clustering. Using 
only these genes, we regressed out unwanted sources of variation and performed dimensionality 
reduction using principal components analysis on the resulting data. After examining the amount 
of variance explained by each principal component, we used the top ten principal components to 
cluster cells using the K nearest neighbors algorithm, and the top ten most differentially 
expressed genes in each cluster were identified. Cell type markers in these lists were then used to 
assign a putative blood cell subtype to each cluster, and clusters were visualized using t-
Distributed Stochastic Neighbor Embedding (tSNE) (van der Maaten and Hinton 2008). These 
plots are shown in Figure 2.1. The workflow used to perform this analysis is available as an R 
Markdown file in the supplementary materials (File S2.1). 
3. Genotyping by SNP array 
A buccal swab was taken from each dog using the Embark Veterinary sample collection 
kit. The samples were then genotyped at 214,504 markers across the entire genome on the 
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Embark Veterinary custom Illumina CanineHD array. The breed mix of the dogs was inferred by 
Embark based on these SNPs, confirming that both dogs were F1 goldendoodles. 
 
4. Identifying ASE-informative sites 
Only heterozygous SNPs are informative for ASE analysis. Based on the SNP array, 
Dog1 and Dog2 were heterozygous at 1,388 and 1,693 X markers on the Embark SNP array, for 
a total of 2,404 unique markers. However, only 5 and 7 of these markers were covered by 
scRNA-seq reads for Dog1 and Dog2, respectively. Therefore, heterozygous sites were also 
identified directly from the aggregate (i.e. pooled across all cells) scRNA-seq data for each dog. 
The aggregate BAM files were run through samtools mpileup followed by bcftools call –m to 
generate a VCF file with, for each cell, base quality and allelic depth data for the reference and 
alternate allele at all sites covered by scRNA-seq reads in that cell. Because reads containing the 
reference allele mapped more confidently to the reference genome, the proportion of reads made 
up by the reference allele at known biallelic sites was typically well over 50% (Figure 2.4). To 
account for this bias, we considered a site to be heterozygous in a given individual if it 1) had at 
least 8 reads covering it across all cells; and 2) had a minor allele frequency of at least 15%. The 
8 read minimum was based on Tukiainen et al. 2017, and the 15% minor allele frequency 
threshold was based on the observed minor allele frequencies at the known heterozygous 
(minimum 20%) and homozygous sites (maximum 14.5%) from the SNP array. We only 
considered biallelic sites where both alleles were SNPs rather than insertions or deletions. Using 
these criteria, we identified 701 and 1,351 X chromosome heterozygous sites across 1,010 and 
656 cells in Dog1 and Dog2, respectively. 
5. Evaluating ASE in single cells 
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For each ASE-informative site, we counted the number of cells for which the site showed 
bi- or monoallelic expression. Sites covered by at least 8 reads within a given cell were 
considered to show biallelic expression within that cell if the minor allele made up at least 10% 
of reads and were considered to show monoallelic expression within that cell if the minor allele 
made up less than 10% of reads. For Dog1 and Dog2 respectively, these criteria identified 178 
and 228 ASE-informative X chromosome sites showing evidence of biallelic expression in 2 or 
more cells, and 184 and 502 showing evidence of monoallelic expression in 2 or more cells and 
biallelic expression in 2 or fewer cells for Dog1 and Dog2, respectively. 
For every X gene, the start and stop positions of the transcription range were taken as the 
union of Ensembl transcript ranges across all transcripts for that gene. The number of ASE-
informative sites showing biallelic expression within each gene’s transcript range was then 
calculated for each gene in each cell. If the average minor allele frequency across all ASE-
informative sites in a gene was at least 10%, it was called as escaping XCI in that cell. If the 
average minor allele frequency across all ASE-informative sites in a gene was less than 10%, it 
was called as X-inactivated in that cell. XCI status calls for all X genes across all cells in both 
dogs (with usable data) are shown in Figure 2.5. 
6. XCI classifications 
If the same gene was called as an XCI escaper in 2 or more cells, it was considered a 
candidate XCI escaper in that individual. If it was not called as escaping XCI in at least 2 cells 
and was called as X-inactivated in 1 or more cells, it was considered X-inactivated in that 
individual. If a gene did not meet either of these criteria, it was considered non-informative for 
XCI status calling in that individual. The consensus XCI status for all X genes is shown in Figure 
2.5.  
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CHAPTER 3 
CONSERVATION OF XCI PROFILES  
ACROSS MAMMALS 
 
Introduction 
XCI and other sex chromosome dosage compensation mechanisms are intrinsically tied 
to the evolutionary histories of the chromosomes they regulate. The therian X and Y 
chromosomes are estimated to have originated from a pair of autosomes ~310 million years ago 
(Mya) (Lahn and Page 1999). Sometime between the divergence of monotremes ~166 (Mya) and 
the divergence of marsupials and placental mammals ~148 Mya (Veyrunes et al. 2008), Sry 
appears to have acquired its dominant sex-determining function (Wallis et al. 2007), accelerating 
X-Y divergence. After this point, a series of large-scale inversions resulted in at least four 
distinct evolutionary “strata” on eutherian X chromosomes corresponding to the degree of 
divergence from Y (Lahn and Page 1999; Pandey, Wilson-Sayres, and Azad 2013), some of 
which are lineage-specific. 
It is unclear when exactly in this history X chromosome dosage compensation originated, 
and in what form. Marsupials lack Xist (Hore et al. 2007) but have their own dosage 
compensation mechanisms including the XCI-mediating long non-coding RNA Rsx (Grant et al. 
2012). Because various forms of imprinted XCI are observed in both marsupials and placental 
mammals, imprinted XCI is assumed to be more ancient than Xist-mediated random XCI 
(Chaumeil et al. 2011; Shevchenko et al. 2013). If this is the case, Xist-mediated random XCI 
likely arose after marsupial-placental divergence at ~148 Mya (Luo et al. 2011) but before the 
most recent common ancestor of extant placentals ~100 Mya (Wible et al. 2007). Since then, 
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lineage-specific X-Y divergence has resulted in substantial variation in the size and gene content 
of the mammalian PARs (Raudsepp and Chowdhury 2015). 
Where do XCI escapers fit into this history? As mentioned in Chapter 1, several studies 
have shown that the length of time for which a given X gene has been diverged from its Y 
gametolog is strongly predictive of its XCI status, with more deeply-diverged genes being more 
likely to be X-inactivated and more recently-diverged genes being more likely to escape XCI 
(Jegalian and Page 1998; Wilson-Sayres and Makova 2013). Assuming that biallelic expression 
is the deep ancestral state for all X chromosome genes, genes escaping XCI have retained their 
ancestral XCI status. Therefore, if an XCI escaper is sufficiently diverged from its Y homolog to 
have stopped recombining with it, its status as an XCI escaper could, broadly speaking, either 
result from inefficient XCI or from some functional constraint related to XCI escape such as 
high/biallelic expression (e.g. X genes in conserved X-Y gametolog pairs located outside the 
PARs described in Bellott et al. 2014). We refer to these two possibilities as the “bug” and 
“feature” models of XCI escape evolution (respectively) in Chapter 1.  
With XCI profiles from multiple therian species, we can add another dimension to the 
“feature” and “bug” models: time. For genes with XCI status calls in three or more species, we 
can infer their likely ancestral XCI status in the common ancestor of those species, and in some 
cases, the location of XCI status changes in the phylogeny. When this information is intersected 
with measurements of selection, we can also identify the specific branches where evolutionary 
constraint or relaxation of constraint likely occurred. For example, if XCI escape is homologous, 
i.e. the conserved ancestral state of orthologous genes, it could have persisted either due to 
ongoing directional selection over millions of years, or simply by chance if selection was relaxed 
prior to the genes diverging. Genes escaping XCI in multiple mammalian lineages fit this 
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homology model, with deeper divergence between the lineages under consideration more 
strongly supporting it. Conversely, XCI escape could have evolved independently in diverged 
lineages either in response to similar selective pressures, or parallel relaxation of selection. 
Parallelism cases could include non-orthologous genes in different lineages that are experiencing 
selection on similar functional feature(s) related to XCI escape. They could also include 
orthologous genes reverting to escaping XCI in multiple mammalian lineages if the ancestral 
gene was already X-inactivated in the common ancestor of those lineages, or cases where the 
gene was not yet diverged from its Y gametolog when two lineages split.  
Using previously published XCI profiles for human, mouse, and opossum together with 
the dog XCI profile described in the previous chapter (the number and proportion of genes 
escaping XCI in each species is shown in Table 3.1)., we performed three analyses to look for 
evidence of convergent evolution of XCI profiles. First, we evaluated conservation of XCI status 
across X chromosome orthologs in human, mouse, dog, and opossum to reconstruct the 
evolutionary history of XCI status changes at these loci. Next, we compared the gene ontology 
annotations of XCI escapers across species to identify shared biological functions. Lastly, we 
compared sequence conservation between XCI escapers and X-inactivated genes within each 
species to evaluate the extent to which the pattern of stronger conservation in human XCI 
escapers compared to X-inactivated that we describe in Chapter 1 of this dissertation genes 
generalizes to other lineages. 
 
Results 
1. XCI profile conservation 
When accounting for the history of X-Y divergence in multiple species, it is important to 
note that the placental and marsupial X chromosomes differ substantially in their gene content 
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due to a large-scale translocation between the ancestral therian X and an autosome in the 
placental lineage ~105 Mya. The region comprised by the ancestral X and conserved between 
placentals and marsupials is referred to as the X conserved region (XCR), and the younger, 
placental-specific translocated region is referred to as the X added region (XAR). In light of this, 
we examined conservation of all one-to-one (1:1) X orthologs across human, mouse, dog, and 
opossum to provide an appropriate basis for comparison to conservation of XCI status. 
We found that while many X genes were conserved across multiple species, including 
225 1:1:1:1 orthologs (Figure 3.1.a), few genes escaped XCI in more than one species (Figure 
3.1.b). Specifically, only one gene, KDMC5, escaped XCI in all four species, and only 18 genes 
escaped XCI in two or more species. Importantly, XIST is not among the shared XCI escapers 
due to its poor sequence homology across mammals. Conservation of X-inactivation was more 
common, with 10 genes X-inactivated in all four species and 118 more X-inactivated in 2/3 or 
3/4 species. 
For each of the 144 genes with an XCI status call in three or more species, we inferred  
its most likely XCI state in the last metatherian common ancestor based on the assumptions that 
the 1) most parsimonious ancestral state was the one requiring the fewest XCI status changes, 
and 2) that all genes share the same tree topology as the species whole genomes, as shown in 
Figure 3.2.a. Following these assumptions, we inferred the most likely locations in the opossum, 
dog, mouse, human phylogeny where these genes switched XCI status. We found that 129 of 
these genes appear to have been inactivated in the common ancestor of opossum, dog, mouse, 
and human. The remaining 15 genes escape XCI in 2/3 or 3/4 species, suggesting that they 
escaped XCI in the common ancestor and have retained that ancestral state these species for over 
300 million years. Of these, 8 became inactivated in the mouse lineage, and 2 became inactivated 
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in the human lineage (Figure 3.2.b). Additionally, 55 genes appear to have been inactivated in 
the metatherian common ancestor and reverted to escaping XCI within individual lineages, with 
12 escaping only in opossum, 16 escaping only in dog, 3 escaping only in mouse, and 24 
escaping only in human (Figure 3.2.c). 
2. Functional conservation 
We obtained PANTHER Gene Ontology Biological Process (BP) annotations for XCI 
escapers in each species, the 18 genes that escape XCI in two or more species, and the 129 genes 
that are inactivated in 2/3 or 3/4 species. Across all gene sets in all species, only 12 BP 
categories were observed: cellular component organization or biogenesis (GO:0071840), cellular 
process (GO:0009987), localization (GO:0051179), reproduction (GO:0000003), biological 
regulation (GO:0065007), response to stimulus (GO:0050896), developmental process 
(GO:0032502), multicellular organismal process (GO:0032501), biological adhesion 
(GO:0022610), locomotion (GO:0040011), metabolic process (GO:0008152), and immune 
system process (GO:0002376). All of these except biological adhesion and immune system 
process appeared in at least one XCI escaper across all four species. The proportion and number 
of genes in each BP category in each group are shown in Figure 3.3. 
3. Sequence conservation 
PhyloP (Pollard et al. 2010) is a method that produces a per-base measurement of 
evolutionary constraint in the context of a given phylogenetic model by looking at the rate of 
DNA sequence change across the branches of the phylogeny in orthologous sequences. Sites 
predicted to be under stronger evolutionary constraint have more positive scores, and sites 
predicted to be under less constraint that have evolved rapidly have more negative scores. The 
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absolute value of a site’s phyloP score corresponds to its negative log p-value for a likelihood 
ratio test under a null hypothesis of neutral evolution. 
 We obtained phyloP scores from the publicly available phyloP100way track in the 
UCSC Genome Browser’s GRCh38/hg38 database. These scores represent estimates of 
departures from neutral evolution across 100 vertebrate genomes, including human, mouse, dog, 
and opossum. For each gene in each species, we pulled all phyloP scores at the human genome 
positions corresponding to that gene’s best local alignment to hg38, including both coding and 
non-coding sequence. The distributions of phyloP scores across all sites in XCI escapers and X-
inactivated genes in each species are shown as violin plots in Figure 3.4. 
 We observed that XCI escapers in dog and opossum have significantly different 
distributions of phyloP scores than X-inactivated genes in the same species (Mann Whitney U 
two-tailed p-values = 2.177e-199 and 2.140e-31, respectively), with XCI escaper and X-
inactivated gene mean phyloP scores of 2.626 and 2.007 for dog and 3.508 and 2.857 for 
opossum. In mouse, the distributions of XCI escaper and X-inactivated genes were not 
significantly different (Mann Whitney U test two-tailed p-value = 0.472), but the XCI escaper 
mean phyloP score (2.793) was higher than the X-inactivated mean score (2.707). In human, the 
distributions of XCI escaper and X-inactivate gene phyloP scores were significantly different 
(Mann Whitney U two-tailed p-value = 0), with a mean phyloP score of -0.012 in XCI escapers 
and 0.244 in X-inactivated genes. We also compared the phyloP score distributions of the 18 
conserved XCI escapers (escaping XCI in two or more linages) and 129 conserved X-inactivated 
genes (X-inactivated in 2/3 or 3/4 lineages) and found that the distributions for conserved XCI 
escapers and X-inactivated genes were significantly different (Mann Whitney U two-tailed p-
value = 0.001), with a mean score of 0.525 in XCI escapers and 0.333 in X-inactivated genes. 
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Conclusions 
In this study, we compared XCI statuses across human, mouse, dog, and opossum one-to-
one X chromosome orthologs. In addition to suggesting that XCI likely existed and was 
pervasive in the common ancestor of therian and eutherian mammals, our results showed that 
XCI escape is poorly conserved across these species and has likely evolved independently in 
multiple lineages at several genes. This observation is consistent with XCI and XCI escape 
evolving in a highly lineage-specific manner, reflecting the different evolutionary histories of the 
X chromosome in each species, such as the addition of the XAR in eutherians and structural 
rearrangements on the X chromosome in each lineage. 
As expected, the proportion of genes escaping XCI mirrors the extent of X-Y divergence 
in each species, as reflected in the size of the PAR in each species: Dog, which has the largest 
PAR at 6.6Mb, has the highest proportion (31%) of XCI escapers, followed by human with a 
PAR size of 2.7Mb and approximately 25% of genes escaping XCI, and then by mouse with a 
PAR size 0.7 and 3-7% of genes escaping XCI. The PAR boundary in opossum is not currently 
confidently mapped. 
The results of our analysis of the conservation of XCI escape across species provide only 
a few examples of genes that fit the homology model of XCI escape evolution, in which XCI 
escape is the conserved ancestral state of orthologous genes. Of the 18 genes that we found to 
escape in two or more of the four species, four (CA5B, KDMC5, FAM122B, and HCFC1) are 
members of deeply conserved X-Y gene pairs. The X gametologs in these gene pairs are 
expected to escape XCI, provided that their Y gametologs have not diverged from their ancestral 
functions, duplicated, or translocated to autosomes (Bellott et al. 2014). A consequence of such 
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divergences is that many of these genes do not have 1:1 orthologs in multiple species and as such 
were not considered in this analysis. 
Most genes escaping XCI in the four species we have considered do so in a single 
lineage, which could result either from retention of the ancestral state of biallelic expression in 
that lineage, or from reversion to XCI escape if the gene was X-inactivated in an ancestral 
species. We observed examples of such genes in all four lineages, but to varying degrees, with 
mouse showing markedly fewer inferred reversions to XCI escape than human, dog, or opossum. 
Without knowing more about the mechanisms of XCI and XCI escape, it is unclear whether 
conservation of ancestral XCI escape in a single lineage or reversion to XCI escape in that 
lineage is more plausible when both scenarios would require the same number of XCI status 
changes. It is also important to note that individual gene phylogenies may not match the species 
phylogeny, which we did not account for. 
Despite XCI escape being highly lineage-specific, we found that XCI escapers in these 
four species overlap highly in their Gene Ontology biological process annotations. Some of 
these, such as cellular process (the most common annotation among the human XCI escapers, 
with 50% falling into this category), provide little insight into these genes’ specific functions. It 
is striking that these genes overlap so extensively in their functional annotations given how few 
of them are orthologous to each other and that in all species XCI escapers represent only a 
fraction of X chromosome genes. However, these annotations were similarly distributed among 
the 129 genes that were inactivated in the majority of species. This may indicate that these 
functional categories are simply common among X chromosome genes rather than being 
associated with a particular XCI status or degree of XCI status conservation. 
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Gene Ontology annotations are more complete in human compared to other species. 
When the human XCI escaper BP annotations are broken down further, the Cellular Process 
category includes histone and protein modification processes such as acetylation and 
deacetylation, suggesting that XCI escapers may play important roles in genome-wide regulation 
of gene and protein expression, in agreement with earlier findings regarding X-linked members 
of conserved X-Y pairs by Bellott et al. (2014).  
Out of all of our results, our analysis of evolutionary conservation in XCI escapers 
provides the strongest support for the parallelism model of XCI evolution by showing that non-
orthologous genes that escape XCI in different species share the common trait of being more 
conserved at the sequence level as a group than X-inactivated genes in the same species. We note 
that the phyloP100way scores for human XCI escapers do not follow this trend, in apparent 
disagreement with our results in Chapter 1. This discrepancy appears to in arise from the 
exclusion of genes with XCI status calls derived from methylation patterns (Cotton et al. 2015; 
Schultz et al. 2015) from this analysis, which was done in the interest of using a consistent 
functional definition of XCI escape across species. It is also worth noting that the phyloP data 
used in this analysis is expected to capture very ancient evolutionary conservation, in contrast to 
our analysis in chapter 1, which looked at conservation only among primates. A general 
conclusion of this analysis is that the magnitude of evolutionary constraint operating on both 
XCI escapers and X-inactivated genes varies substantially by lineage, and across genes in each 
XCI class within lineages. 
Recently, Naqvi et al. 2018 showed that based on conserved microRNA-gene 
interactions, sensitivities to gene dosage increase appear to have been conserved from ancestral 
amniote autosomes between many inactivated X and Z genes in mammals and birds. In contrast, 
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human XCI escapers show significantly less dosage sensitivity conservation by this same metric. 
The authors of this study suggest that this indicates that XCI escapers tend to be less sensitive to 
dosage increases than other X genes, with the exception of XCI escapers that are members of 
deeply conserved X-Y gene pairs. It is not yet clear to what extent this trend generalizes to other 
mammalian species, but it is consistent with our finding that more recent selection and/or 
relaxation of selection could be occurring on the distal branches of the mammalian phylogeny, 
potentially reflecting a higher tolerance for dosage changes among XCI escapers. Further 
comparisons of lineage-specific evolutionary conservation among XCI escapers and X-
inactivated genes in these and other species will be necessary to investigate this possibility. 
Overall, we find evidence that XCI escape at individual genes can evolve according to 
either homology or parallelism scenarios, but that parallelism is likely more common. These 
results suggest there are likely multiple mechanisms by which a gene’s XCI status can evolve in 
addition to the extreme cases of strong constraint or extensive relaxation of selection. Generation 
of comprehensive XCI profiles for additional mammalian species will be necessary to further 
clarify the complicated history of XCI evolution. Additionally, the analyses performed in this 
study have limited ability to differentiate between genes that escape due to selective pressures 
and genes for which XCI escape is merely a result of inefficient XCI. We hope to address this 
possibility in the future by applying methods that more explicitly test for relaxation of purifying 
selection along individual branches of a phylogeny. 
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Methods 
1. Processing of previously-generated ASE-based XCI profiles 
When XCI status is assayed by ASE, different criteria may be used to categorize it as 
escaping, inactivated, or any number of intermediate states. In this analysis, these classifications 
must be applied as consistently as possible across the different data sets to ensure that 
meaningful comparisons are being made. ASE-based XCI profiles are available for human 
(Carrel and Willard 2005), mouse (Berletch et al. 2015), and opossum (Wang et al. 2014), each 
of which used slightly different definitions of XCI escape and XCI status categories based on 
methodology and samples. 
Carrel and Willard’s definition of an XCI escaper was genes showing an Xi/Xa expression 
ratio of at least 10% in at least 7 of the 9 XX human-murine hybrid fibrobast cell lines they 
tested. The remaining genes were considered either “heterogeneous” escapers, or X-inactivated. 
Berletch et al. obtained their XCI status calls from bulk RNA-seq of brain, ovary, and spleen 
samples from two female BL6 x Spretus F1s. They defined XCI escapers as genes showing a 
significant probability (per a binomial test) that the degree of Xi expression was greater than 
expected for a monoallelicaly expressed gene given the total number reads of each allele 
observed for that gene. All genes that did not meet this criterion were considered X-inactivated. 
Wang et al. acquired XCI status calls by performing bulk RNA-seq on brain samples from four 
female F1 LL1 x LL2 individuals, and defined XCI escapers as genes showing an Xi:Xa 
expression ratio of at least 10% in at least one individual. All other genes were considered either 
X-inactivated, except a few which were annotated as candidate escapers based on showing non-
zero Xi expression of less than 10% of Xa expression. In the previous chapter, we described 
calling XCI status in dog based on the average minor allele frequency across heterozygous sites 
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within each gene, with genes showing an average minor allele frequency of 10% or greater in 
two or more cells in the same individual called as escaping XCI, and those with an average 
minor allele frequency of less than 10% in one or more cells in a single individual called as X-
inactivated. To minimize differences in the functional definition of XCI escape across species, 
we re-called XCI statuses in all three data set using an Xi:Xa expression ratio of at least 10% in at 
least 25% of individuals as the cutoff for calling a gene an XCI escaper.  
Additionally, to compare XCI statuses across the three species, it was necessary to update 
the gene names used in each XCI profile. Gene identifiers from each XCI data set were cross-
referenced with the Ensembl 89 data base to get up-to-date Ensembl gene IDs, and discard genes 
without Ensembl gene IDs or update/consolidate those with retired IDs. Following these steps, 
we were left with 451, 543, 152, and 168 genes with both an XCI status call and an Ensembl 
gene ID in human, mouse, dog, and opossum, respectively. The data are available in the 
supplementary materials (File S3.1). 
2. Orthology 
Ortholog data for human (GRCh38.p10), mouse (GRCm38.p5), dog (canFam3.1) and opossum 
(monDom5) was downloaded from the Ensembl data base (release 89) (Zerbino et al. 2018). 
These included the gene IDs, chromosome/scaffold, and homology type for each gene in each 
species. We were only interested only in one-to-one X chromosome orthologs, meaning that a 
given X gene had exactly one best match ortholog, also on the X chromosome, in each of the 
other species it was being compared to. The one exception to this definition was when an X gene 
in one species was strongly homologous to both members of an X-Y gametolog pair in another 
species. For instance, the opossum X gene KDM5C (ENSMODG00000009765) has two 
orthologs in human: KDM5C (ENSG00000126012) on the human X, and KDM5D 
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(ENSG00000012817) on the human Y. Although the two human genes differ, they originated as 
a homologous pair and only recently stopped recombining, meaning that neither is a duplicate of 
the other. Therefore, we can effectively treat the relationship between ENSMODG00000009765 
and ENSG00000126012 as one-to-one. 
To account for any possible discrepancies in annotations across the data sets for different 
species, we further filtered the gene data sets to ensure that gene list memberships were 
reciprocal among compared species, meaning that each one-to-one X ortholog list for a given set 
of species was identical regardless of which species’ data set it was generated from. Final gene 
lists are available in the supplementary materials (File S3.2). 
3.  Gene ontology comparisons 
We obtained PANTHER Gene Ontology Biological Process (BP) annotations for XCI 
escapers in each species from http://www.pantherdb.org/ (Version 13.1, accessed May 3rd, 2018) 
(Mi et al. 2017). These are available in File S3.3. Queries were the Ensembl gene IDs for XCI 
escapers and X-inactivated genes from each species and the 144 conserved genes, which are 
available in the File S3.3. 
4. Sequence conservation comparisons 
The phyloP100way track in the USCS Genome Browser hg38 database was queried using 
the UCSC Genome Table Browser tool (http://genome.ucsc.edu/cgi-bin/hgTables) (Karolchik et 
al. 2004). Each query consisted of human genomic intervals corresponding to each mouse, dog, 
and opossum gene. These intervals were obtained by using the Ensembl BLAT (Kent 2002) web 
tool (ensembl.org/Multi/Tools/Blast) to pull the DNA sequence for each gene by its Ensembl 
gene ID and align it to the human (hg38) genome sequence. For each gene, the human interval 
with the highest E score was taken as the best alignment, and phyloP100 way scores were pulled 
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from the corresponding genomic intervals in the phyloP100way track. The Ensembl gene IDs 
and corresponding hg38 genomic intervals are provided in File S3.4, and phyloP scores for each 
interval for each species and conserved genes are provided in File S3.5. 
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CHAPTER 4 
DISCUSSION 
 
Summary  
In this dissertation, I have described three projects unified by the goal of better 
understanding the evolutionary drivers and history of XCI escape. In the first, I showed that 
human XCI escapers tend to show higher and broader gene expression in both males and females 
in addition to stronger evolutionary constraint since the divergence of the human lineage from 
other primates. This piqued my interest in the possibility that XCI escape might have important 
biological consequences in humans and perhaps other mammals, but it was clear that with 
limited data from other species, we had insufficient information to rigorously evaluate this 
hypothesis. 
 Subsequent publication of more comprehensive XCI profiles for opossum (Wang et al. 
2014) and mouse (Berletch et al. 2015) introduced the possibility of performing an informative 
cross-species comparison of XCI profiles. Motivated by this, I next used newly-available 
scRNA-seq technology to generate an XCI profile for the domestic dog. I then incorporated those 
data into an analysis of conservation of XCI profiles across human, mouse, dog, and opossum 
1:1 X orthologs. This analysis produced two main findings: First, XCI escape is highly lineage-
specific, with several XCI escapers appearing to have reverted to biallelic expression after 
previously evolving to become inactivated. Second, there is extensive heterogeneity in 
evolutionary conservation within XCI categories in each species. 
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Implications 
 This project began as an investigation into whether or not XCI escapers showed distinct 
patterns of genetic diversity in humans compared to other X chromosome genes, which was 
motivated by prioritizing genetic association results in human disease studies. In the five years 
since then, the work that I and others have done on XCI escape has produced results that 
sometimes appear contradictory. The results described in the previous chapter of this dissertation 
shed some light on these contradictions by demonstrating that the history of XCI profile 
evolution has been more complex than existing models generally account for. Taken together, 
the evidence seems to suggest that XCI escape is neither necessarily a consequence of selection, 
nor necessarily a neutral feature resulting from inefficient XCI. The majority of genes appear to 
fall somewhere between these two extremes. Consequently, I believe that we should be cautious 
in treating XCI classes as functionally cohesive groups. 
Our findings support previous predictions that XCI occurred in the common ancestor of 
marsupials and placentals. Additionally, our observation that XCI escape is deeply conserved for 
a handful of genes suggests that XCI escape might also have occurred in this common ancestor. 
It remains unclear whether the mechanism of XCI in this ancestor would resemble the 
chromosome-wide XCI seen in mammals, the gene-specific silencing seen in the avian Z 
chromosome (Itoh et al. 2007), or neither. However, the large number of genes that are X-
inactivated across multiple species could be interpreted as evidence that XCI was pervasive 
across the chromosome. Incorporating XCI profiles from additional species might further clarify 
these points. 
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Future directions 
While this work has provided novel insights into the evolutionary origins of XCI escape, 
it perhaps most importantly serves to motivate future experiments that more directly interrogate 
the functional impacts and mechanisms of XCI escape. For example, gene knock down or knock 
out experiments in female animals or cell lines can help clarify the extent to which the generally 
small gain in transcript abundance contributed by XCI escape is necessary or sufficient for 
various phenotypes. Phenotypes associated with human X aneuploidy syndromes, such as 
fertility and neurological development, may be of particular interest. These approaches combined 
with scRNA-seq could prove extremely powerful for investigating the impact of abnormal XCI 
patterns on genome-wide transcription at the cell level. 
Another intriguing opportunity for further investigation is afforded by technologies that 
capture the three-dimensional organization of chromatin inside cells, such as 5C (Dostie et al. 
2006; Ferraiuolo et al. 2012) and HiC (Lieberman-Aiden et al. 2009). Combining the topological 
data provided by these methods with DNA sequence motif detection tools could vastly improve 
our understanding of how specific regulatory elements affect XCI status of nearby genes. 
Chromatin conformation capture studies of the Xi have already solidified a role for LINE 
elements and the CTCF binding sites in XCI (e.g. Berletch et al. 2015; Deng et al. 2015), but 
modern computational methods could accelerate this process. For instance, A 2006 study (Wang 
et al.) had limited success in using a machine learning approach to identify DNA sequence 
motifs that were predictive of XCI status in human, but a similar strategy could perhaps be taken 
to identify sequence elements associated with specific Xi topological associated domains defined 
by chromatin conformation capture data. 
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Lastly, the observation that XCI escape evolves relatively rapidly and varies substantially 
among species raises the possibility that XCI status could contribute to or result from species-
specific biological features. The hypothesis that regulatory evolution underlies much of the 
phenotypic differences between species is well established and widely supported (e.g. King and 
Wilson 1975; Brawand et al. 2011; Diehl et al. 2018). Given the important role of several XCI 
escapers in brain development (reviewed in Berletch et al. 2011) and overall enrichment for 
brain development genes and brain expression on the mammalian X chromosome (Zechner et al. 
2001; Skuse 2005; Nguyen and Disteche 2006), investigating evidence for lineage-specific 
positive selection on XCI escapers and associated cis-regulatory elements might lead to 
interesting discoveries. 
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TABLES AND FIGURES 
 
 
Chapter 1: 
 
Figure 1.1: XCI escaper to X-inactivated gene ratios of fraction of sites under strong 
purifying selection (S) and fraction of neutral sites (N) by Y gametolog status. 
 
 
Fig. 1.1: XCI escapers show larger fractions of sites under strong purifying selection 
(S) and smaller fractions of neutral sites (N) than X-inactivated genes with the same 
Y gametolog status. XCI escaper-to-X-inactivated ratios of the values of N and S are 
presented, with standard deviations based on 1000 bootstrap samples of genes in each 
XCI/Y category (error bars denote ±1 standard deviation). The numbers (n) of XCI 
escaper and X-inactivated genes in each Y gametolog category are shown below the 
category names at the top of the plot. The Whole ChrX category includes genes from all 
other categories, as well as 18 genes that did not have a Y gametolog status assignment 
(12 XCI escapers and 6 X-inactivated genes). The No Y category is the union of the 
Pseudogenized and Lost Y categories. 
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Figure 1.2:  
1.2.a: XCI category average gene expression for genes by XCI/Y status, tissue and sex. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Fig. 1.2.a: XCI category average gene expression by Y gametolog status, tissue and 
sex. Scatterplots show the XCI/Y category averages of gene expression values for each 
sex in each GTEx tissue. Shaded areas show the standard deviation of the average across 
genes. In both plots, individual expression values were filtered by tissue-specific cutoffs 
(Methods) before being incorporated into gene averages. 
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1.2.b: Global mean expression for each gene by XCI/Y status and sex.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.2.b: Global mean expression for each gene by XCI status, Y gametolog status, 
and sex. Each point in these one-dimensional scatterplots shows the global mean 
expression value of a single gene in female (left) and male (right) samples. The white 
diamonds indicate the mean expression value of the genes in that XCI/Y category. Areas 
of darker color indicate overlap of two or more points. In both plots, individual 
expression values were filtered by tissue-specific cutoffs (Methods) before being 
incorporated into gene averages. 
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Figure 1.3: Gene tissue specificity index (t) by XCI/Y status and sex. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.3: XCI escapers are more broadly expressed than X-inactivated genes with the same 
Y gametolog status in both sexes: Points show τ statistic values for all genes in each XCI/Y 
category for female (left) and male (right) samples. White diamonds show the mean of τ across 
all genes in that XCI/Y category. Areas of darker color indicate overlap of two or more points. 
Values of τ range from 0 to 1, with higher values corresponding to greater tissue-specificity. 
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Figure 1.4: Proportion of tissues in which each gene shows significant expression (using 
3SD cutoffs) by XCI/Y status and sex. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.4: XCI escapers show significant expression in a higher proportion of tissues 
than X- inactivated genes with the same Y gametolog status. Each point represents the 
proportion of 23 broad tissue types (excluding sex-specific tissues) for which a gene 
showed significant expression using the 3SD cutoff described in the text. Gene 
membership of each XCI/Y category was resampled with replacement 1000 times, and 
the mean value of these samples for each category is shown as a white diamond.  
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Table 1.1: Resampling mean and standard deviation of S and N for XCI/Y categories in 
the combined XCI data set. 
Y Category XCI category n Genes S N 
All 
XCI Escapers 248 0.52+/-0.02 0.46+/-0.02 
X-inactivated 238 0.39+/-0.03 0.57+/-0.03 
Functional Y 
XCI Escapers 11 0.60+/-0.06 0.37+/-0.05 
X-inactivated 4 0.63+/-0.13 0.32+/-0.14 
Pseudogenized Y 
XCI Escapers 102 0.52+/-0.03 0.47+/-0.03 
X-inactivated 108 0.39+/-0.04 0.58+/-0.04 
Lost Y 
XCI Escapers 123 0.50+/-0.04 0.47+/-0.04 
X-inactivated 120 0.38+/-0.04 0.57+/-0.04 
No Y  
(Pseudo.+ Lost Y) 
XCI Escapers 225 0.52+/-0.02 0.47+/-0.02 
X-inactivated 228 0.39+/-0.03 0.57+/-0.03 
 
Table 1.2: Global mean expression ratios using various expression minima. 
 
 
 
 
 
Table 1.2: XCI/Y category global mean expression level ratios for significantly 
expressed genes using different minimum expression cutoffs. XCI escaper-to-X-
inactivated global mean expression ratios are shown for each Y gametolog category in 
both sexes. P-values (shown in parentheses) are the proportion of 1000 permutations of 
gene category membership for which the expression ratio was greater than or equal to the 
observed ratio. “EF” denotes XCI escapers with functional Y gametologs, “IF” denotes 
X-inactivated genes with functional Y gametologs, “EN” denotes XCI escapers with no 
Y gametologs, and “IN” denotes X-inactivated genes with no Y gametolog.  
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Table 1.3: Resampling mean and standard deviation of the tissue specificity index (τ) for 
XCI/Y status categories in females and males. 
Y Category XCI category n Genes Female τ Male τ 
Functional Y 
XCI Escapers 11 0.51+/-0.06 0.52+/-0.06 
X-inactivated 4 0.73+/-0.11 0.68+/0.11 
No Y  
(Pseudo.+ Lost Y) 
XCI Escapers 225 0.68+/-0.01 0.67+/-0.01 
X-inactivated 226 0.75+/-0.01 0.75+/-0.01 
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Chapter 2: 
 
 Figure 2.1: Pedigree of Dog1 and Dog2 
 
 
Fig. 2.1: The breed, sex, and the identity of X chromosomes of the parents of Dog1 and 
the parents and grandparents of Dog2 are shown, as well as for the half-sister of 
Dog1/aunt of Dog2 (individual II-1). Saliva samples from individuals II-1 and II-3 were 
subject to shallow whole-genome sequencing to facilitate phasing of the Dog1 and Dog2 
scRNA-seq data (analysis ongoing). Individual I-2, the father of Dog1, is deceased and 
could not be sampled. 
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Figure 2.2: tSNE plots of PBMC cell subpopulations in scRNA-seq samples. 
Fig 2.2.a: Dog1 PBMC populations. 
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Fig 2.2.b: Dog2 PBMC populations.     
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Figure 2.3: Example raw scRNA-seq data for genes with known expression patterns. 
Fig. 2.3: These panels show Integrative Genome Viewer (IGV) screenshots of read 
alignments from individual cells at two genes – one that is known to be expressed solely 
from Xi, and one in the PAR that is expected to show biallelic expression 
 
 
 
 
 
Fig. 2.3.a: XIST, the RNA that 
mediates XCI and is solely 
expressed from Xi,  shows 
monoallelic expression (with 
some error). 
 
Fig. 2.3.b: ARSE, a PAR 
gene, shows expression of 
multiple alleles. 
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Figure 2.4: Fraction of reads at ASE-informative sites coming from the reference allele across 
all cells. 
Fig. 2.4.a: Dog1 chrX.          Fig. 2.4.b: Dog2 chrX. 
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Chapter 3: 
 
Figure 3.1: ChrX gene overlap among human, mouse, dog, and opossum. 
  Fig. 3.1.a: Overlap among 1:1 X orthologs.                      
 
Fig. 3.1.b: Overlap among XCI escapers. 
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 Fig. 3.1.c: Overlap among X-inactivated genes. 
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Figure 3.2: Inferred locations of XCI status changes in the opossum, dog, mouse, human 
phylogeny. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2.a: Phylogeny for opossum, dog, mouse, and human. 
 
Fig. 3.2.b: Number of genes changing from XCI escapers to X-inactivated genes, colored 
by the lineage in which the change occurred. 
 
Fig. 3.2.c. Number of genes reverting from X-inactivated to escaping XCI, colored by 
lineage in which the change occurred. 
 
 
 
 
 
 
 
 
 
 
 
 
 76 
Figure 3.3: PANTHER Biological Process terms for XCI escapers by species.  
 
 
Fig. 3.3: Bars show the percentage (top) and 
 number (bottom) of XCI escapers genes in each  
species and in the genes that escape XCI in 
two or more species (Conserved_E) or are 
X-inactivated in 2/3 or 3/4 species 
(Conserved_I) that have each of the twelve  
Gene Ontology Biological Process  
annotations observed across these species  
(right). 
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Figure 3.4: 100-way vertebrate phyloP scores by XCI status for each species. 
 
 
 
Fig. 3.4: Violin plots of phyloP 100-way (vertebrate) conservation scores for XCI 
escapers (“E”) and X-inactivated genes (“I”) in each species. The black rectangles 
inside each violin plot show the interquartile ranges, while the white points show 
the medians. 
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Table 3.1: XCI profile summaries for all species. 
Species # Informative X genes # XCI escapers 
Human 612 155/612 (25%) 
Mouse 542 38/542 (7%) 
Dog 143 45/143 (31%) 
Opossum 176 24/176 (13%) 
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